Entities

Daegwon Chae is a BOND partner investing in technology businesses across industries. His published biography identifies board service at Halter, inDrive, Suno and Toss, and investment involvement with Cognition, Databricks, Ineffable Intelligence, OpenAI and Wiz. He previously worked as a principal at Kleiner Perkins and invested in growth businesses in Goldman Sachs’ Special Situations Group.

David Lu is an investor at BOND whose work spans global technology businesses. He previously invested in private equity at Permira and worked in investment banking at Credit Suisse. BOND links his professional profile to davidlu373; he is distinct from David Lu, the Clarity Movement co-founder.

Grant Watson is an investor at BOND researching technology trends and growing technology businesses. He previously served as a Boston Consulting Group project leader in San Francisco and London, advising consumer and enterprise software companies.

Jay Simons is a general partner at BOND focused on enterprise software and scaling SaaS businesses. His published biography identifies board service at Baseten, BrowserStack, HubSpot, KoBold Metals and Zapier, and investment involvement with AlphaSense, ElevenLabs and VAST Data. He previously served as Atlassian’s president, helping develop its commercial model and acquisitions strategy, and held marketing and sales positions at BEA Systems and Plumtree Software.

Jesse Ellingworth is a principal at BOND covering consumer internet and financial technology. Earlier roles included growth investing at Kleiner Perkins and technology mergers and acquisitions advisory at Qatalyst Partners.

Kate Roberts leads BOND’s finance function, including fund reporting, audits, tax and internal financial operations. She is a UK Chartered Accountant who began in financial services auditing in London. Her background includes leading finance at a fund administrator through acquisitions and private equity ownership, and serving as outsourced CFO to investment managers.

Katie Denton is a principal at BOND investing in software, artificial intelligence and internet businesses. She previously worked in growth equity at KKR and in technology investment banking at Goldman Sachs.

Keeyan Sanjasaz is a principal at BOND investing in software and internet businesses internationally. He previously worked as an investment banker at Goldman Sachs.

Mary Meeker is a general partner at BOND investing in growing technology businesses. Her published biography identifies board service at Block, Genies and OpenEvidence, and investment involvement with Applied Intuition, Canva, Ironclad and Multiverse. She previously co-led Kleiner Perkins’ Digital Growth Fund team, which became BOND in2019, and led global technology research at Morgan Stanley. She is known for the Internet Trends reports, first published in1995, and holds a BA from DePauw and an MBA from Cornell. Earlier Kleiner Perkins investments and the aggregate commitments of three legacy funds are historical background, rather than new BOND financing events.

Mood Rowghani is a BOND partner investing in technology businesses internationally. His published biography identifies investments including Canva, Cockroach Labs, Ironclad, SpaceX and Whatnot, and board service at Carbon Robotics, inDrive, Partiful and Substack. He previously co-led Kleiner Perkins’ Digital Growth Fund and worked at Summit Partners, McKinsey and Highland Capital Partners. Investments made at earlier employers are historical background, rather than additional BOND checks.

Noah Knauf is a BOND partner focused on healthcare, financial technology, gaming and frontier technology. His published biography identifies board service at AKASA, Saildrone, Sidecar Health and Sunday, and investments including Locus Robotics, Maven Clinic and SWORD Health. He previously co-led Kleiner Perkins’ Digital Growth Fund team, which became BOND in2019, and worked at Warburg Pincus, Bain and Parthenon Capital. The three legacy Digital Growth Funds’ aggregate committed capital is distinct from new BOND fund closings.

Paul Vronsky is BOND’s operating partner, responsible for firm strategy, investments, fund operations and regulatory compliance. He previously served as a partner at Vy Capital and as Kleiner Perkins’ general counsel, and began his legal career at Gunderson Dettmer. He holds a BS from the University of Washington, an MPhil from Oxford and a JD from Stanford.

Rob Scales is a BOND partner backing frontier and emerging technologies across stages and countries. His published investment involvement includes Base Power, Cognition, Decagon, ElevenLabs, HeyGen, Quantum Systems and Suno. He previously invested at Blackstone, worked in Goldman Sachs’ technology, media and telecommunications investment banking group, and led product and commercial teams at startups.

Taha Ziaee is a BOND partner investing in technology businesses. His published investment involvement includes AKASA, Applied Intuition, ClickHouse, Databricks, OpenAI, OpenEvidence and Wiz. He previously worked in private equity and growth investing at TPG and in technology mergers and acquisitions at Centerview Partners.

Will Wnekowicz is BOND’s chief technology officer. He develops the firm’s technology strategy, sourcing systems and portfolio monitoring tools, and oversees cybersecurity and technology risk. His background includes product engineering, finance and data science.

Aaron Botwick is named in full by AeroVect’s current official safety page and by the22January2026 PAVE interview. The issuer’s older appointment post abbreviated his surname as Aaron B.; these primary publications establish one same safety leader. The issuer describes autonomous-driving safety-case, fault-management and reliability experience at Cruise, Aurora, Uber ATG, Lockheed Martin and Orbital Sciences. His genuine issuer-published photograph is preserved; the full public name is verified from the official current safety page rather than inferred from a private identity.

Laura Popa, PhD, PMP, is AeroVect’s Staff Systems Architect in the issuer’s named appointment announcement. Her published career spans sensor design at Analog Devices, technical consulting at Exponent and autonomous systems work at Argo AI and Forterra. AeroVect describes responsibility for architecture and alignment of its next-generation autonomous ground-support platform; product-performance claims remain source-qualified.

Garrett Stair is AeroVect’s published Staff Systems Engineer in its own appointment announcement. The issuer describes autonomous-vehicle architecture, requirements and hardware integration experience at Torc Robotics, along with prior airfield-related research work. His exact authentic portrait could not be recovered from the accessed primary announcement, and no substitute face is supplied.

Josh Ayers is AeroVect’s General Manager of Atlanta Operations, explicitly announced by the company and co-founder Eugenio Donati. His published background includes logistics/transportation leadership at DHL Supply Chain, scaling warehouse and transport networks and operational safety/compliance. The cited former warehouse revenue is not AeroVect revenue or financing.

Stephen Bradford is AeroVect’s published Head of Systems. The issuer announcement and his own post describe previous Cruise autonomous-vehicle systems engineering, requirements and verification/validation leadership, plus complex product-development consulting. The source supports a professional appointment rather than a personal investment, and no precise startday is invented.

Spyros Zafeiropoulos, also explicitly named Spyridon by AeroVect, joined as VP of Engineering in the issuer’s public appointment announcement and his own corroborating post. His published background includes engineering leadership in automotive/autonomy at Delphi, Aptiv and Cruise. The source bridges the public Spyros/Spyridon name rather than creating two people; exact employment-start day is undisclosed.

Lyndsay Polycranos is AeroVect’s Deployment Manager in the issuer’s current careers testimonial. Her named publication discusses deploying airport autonomy and the company’s engineering/operations culture. The genuine issuer photograph is matched to that named testimonial; no unrelated Lyndsay profile or presumed executive title is merged.

Eugenio Donati is AeroVect’s co-founder, named by the current company site and the2026 Italian Symposium organiser with an authentic individual portrait. The founders met at Harvard through a shared interest in aviation and developed autonomous ground-support equipment. Future Back Ventures identifies him as a former Bain consultant in Johannesburg and Lagos. Older2022 issuer quotations call him COO; the current company publication confirms co-founder and does not establish a new COO appointment date.

Raymond Wang is AeroVect’s co-founder and CEO, identified as CEO by the issuer’s own public announcement. His Harvard computer-science education included AI and machine learning. Harvard’s2023 alumni profile discusses his aircraft-airflow invention, Delta/Microsoft internships and building an autonomous baggage-tractor prototype with Eugenio Donati. These technical projects are career context rather than proof of every investor or present aircraft-certification claim.

AeroVect is an industrial autonomy company developing AI-powered self-driving systems for airport baggage and cargo ground-support equipment. Its issuer identifies the legal company as AeroVect Technologies Inc. at aerovect.com. The AeroVect Driver combines perception, tracking, localization and planning to operate ground vehicles around aircraft, staff and other airside traffic. Its deployment model is OEM-agnostic rather than requiring an airport to replace every tractor with a new vehicle. Product superlatives and safety-performance totals are company claims, not independently established benchmarks. This is applied AI, robotics and industrial deep technology; no neuroscience or medical-device claim is made. The current own company page names co-founders Raymond Wang and Eugenio Donati, a San Francisco headquarters and offices in Atlanta, New York, Toronto and Frankfurt. Wang’s Harvard biography describes computer-science/AI education, prior aircraft-airflow work and the early autonomous baggage-tractor prototype. Harvard’s2023 story says the company launched in2021, while investor Graphene and the2026 founder symposium use2020; no exact legal incorporation day is guessed from that difference. AeroVectRx, the unrelated aerosol-drug-delivery company, and Oman’s AeroVecto are distinct businesses. The genuine published team scope comprises the two founders, Deployment Manager Lyndsay Polycranos, and six explicit issuer/social appointment announcements: engineering leader Spyros/Spyridon Zafeiropoulos, systems lead Stephen Bradford, Atlanta operations General Manager Josh Ayers, Staff Systems Engineer Garrett Stair, Staff Systems Architect Laura Popa and Head of Safety Aaron Botwick, named in full on the official safety page and in the2026 PAVE interview; the older hiring post abbreviated his name as Aaron B. More engineering staff are mentioned in conference posts, but incomplete first names, tagged event attendance and third-party contact directories are not manufactured into exact current employee roles. The company’s unused Forerunner website-template pages show fictitious executives and stock portraits; those are excluded. Actual primary investment evidence includes Xfund’s9January2022 founder interview, Harvard’s2023 identification of Xfund as an early investor, Graphene Ventures’ own2022 Seed portfolio entry, and Future Back Ventures by Bain & Company’s own investment announcement subsequently corroborated by Wang. The exact Xfund round, closing day, security, fund allocation and ticket are undisclosed. Graphene supplies a2022 investment year and Seed stage without a cash amount or exact day. Future Back’s published investment does not establish membership in a specific2024priced round. The CEO’s own late2024 recruiting post independently confirms Series A backing, but supplies no cash amount, closing date or subscribing investors. Secondary databases report roughly USD2million pre-seed, USD7million seed and USD18million SeriesA with conflicting single-day dates and cumulative totals. Those claims remain research gaps until a primary issuer, investor or statutory offering source establishes actual amounts and allocations. Separate amount/date-NULL relationship records preserve the verified institutional backing without converting a publication date, prototype development budget or database total into paid financing. Counterparty profiles for Graphene and Future Back require full enrichment before institutional participation writes; no bare manager or automatic Bain-parent double check is created.

Bondus is a Dutch microfluidic manufacturing company that helps diagnostic and life-science developers turn small fluid-handling devices into repeatable, scalable products. It develops processes for bonding polymer layers while preserving microscopic channels, producing sealed devices, flow cells and manifolds for lab-on-a-chip systems, point-of-care diagnostics and biosensors. Its services span prototyping, process validation and recurring contract manufacturing, including bonding, coating, assembly, CNC machining and micro-dispensing. Bondus also manufactures microfluidic organoid plates with structured culture environments in standard 96- or 384-well formats, and supplies hardware and coating processes for three-dimensional tissue research. Customers use these manufacturing capabilities to move from a working laboratory design to controlled production. The company operates in Zwolle and describes an ISO 13485-certified quality management system for manufacturing bonded polymer microfluidic products.

Co-founder of Bondus, publicly identified as its CEO in the company’s own news and October 2025 financing announcement. His work focuses on developing scalable manufacturing processes for microfluidic products. A primary university interview describes his role in forming the business with Sven Eijpe and moving its technology towards production.

Named as Bondus’s design engineer in a direct October 2024 university interview with co-founder Bas-Jan Hoogenberg, after initially joining as an intern. His self-published profile lists Bondus and education at Hogeschool Utrecht. The current precise job title and working hours are unverified.

Named as an early Bondus collaborator in its incubator’s May 2022 company interview. The profile described him as a biomedical technology master’s student with an interest in robotics and programming. An exact company office, founder title or current affiliation has not been verified.

Co-founder of Bondus, developing precision processes for manufacturing polymer microfluidic devices. Technology partner Gain identified him as CTO in August 2023. His self-published profile describes biomedical engineering at the University of Twente and research into production methods for medical self-tests; his current executive title has not been independently confirmed.

Alexander Huber oversees UVC’s finance, operations, legal and compliance work. His experience includes fund administration, financial control and structuring support for portfolio-company financings.

Alexander Kiltz invests in B2B software and leads UVC’s Berlin office. His background combines finance and electrical engineering studies with startup experience.

Amanda-Stella Birkenholz invests in deep tech and climate technology. Her background includes industrial engineering at RWTH Aachen and co-founding B2B startup VISN.

Andreas Unseld co-founded UVC Partners and invests in B2B software, deep tech and mobility. His portfolio experience includes AI, fleet software, electric-drive systems and LiDAR.

Benjamin Erhart invests in deep tech and engineering software. His portfolio experience includes quantum computing, robotics and climate technology, with a technical background from KIT.

Carmen Specht works on marketing and communications. Her experience includes startup and fund communications, START Munich and founding a female-entrepreneurship initiative.

Christoph Droste combines data-science training at UCL with energy-transition operating experience at Enpal and Flexa.

Eric Jacob works on investment analysis. His background includes management studies in London and Rotterdam, startup go-to-market work and consulting experience.

Geart Ferhati works on AI automation at UVC Partners. His background includes founding software ventures and studying data and AI engineering at the Technical University of Munich.

Harshul Bhatt works on data and AI engineering. He studied engineering physics at IIT Bombay and gained research experience at KAIST and Indiana University.

Helmut Schönenberger co-founded UnternehmerTUM and serves in TUM’s entrepreneurship leadership. His background includes aerospace engineering, founding businesses and venture investing.

Hendrik Reents scouts European deep-tech companies. His experience includes industrial decarbonization consulting and work at battery-recycling startup tozero, alongside chemistry and business studies.

Ingo Potthof is a technology investor with international venture-capital experience across Europe, Israel, the United States and Asia.

Jana Petry invests in climate technology and future-of-work businesses. Her background includes management, finance and computer-science studies at TUM and CDTM.

Johannes Brunner works on UVC’s finance operations. He previously worked on accounting advisory, valuations and transaction analysis at PwC and studied finance and accounting.

Johannes von Borries helped build UVC’s investment platform. His experience includes co-founding and exiting semiconductor-inspection company Nanda Technologies and studying industrial engineering and business administration.

Joyce Galang combines startup engineering experience with data science and computer-engineering studies. Her research at TUM includes natural-language processing and explainable AI.

Laura Gitt works on marketing and design at UVC. She studied communication and media design and gained experience in e-commerce, agencies and freelance design.

Luca Koch works on growth-stage investments. He previously advised on M&A and private-equity transactions at BCG and studied at WHU and the Stockholm School of Economics.

Maria Poursaiadi leads UVC’s marketing and communications. Her career spans editorial work, public relations, research and technology-brand communications, informed by studies in law and economics.

Maximilian Birnboeck works on investment analysis while studying technology and management at TUM. His experience includes consulting, family-office work and fundraising for a student carbon-removal initiative.

Mika Voss works on investment analysis. He studied economics and data analytics at the University of St. Gallen, with research on predicting startup performance.

Nikias Göpfert works on finance and internal business intelligence. His background includes audit, transaction advisory and strategy and finance studies in Vienna and Munich.

Niklas Frost supports portfolio-company strategy and operations in UVC’s value-creation team. His background includes management and digital-technology studies at LMU Munich.

Oliver Schoppe invests in AI, enterprise software and digital health. His background combines electrical engineering, neuroscience and AI research, including work at the Helmholtz Center.

Renate Fuhrich supports UVC’s administration, events and scheduling. Her previous office-management experience includes healthcare and sports and entertainment businesses.

Sabine Mattern manages UVC’s relationships with limited partners and fundraising communications. Her background includes international business studies and investor-event and project coordination.

Sandra Löchinger supports team organization and events. Her prior experience includes tourism management, coordinating trips and projects, and public-service administration.

Sarah Theinert leads UVC’s portfolio-support practice. She combines business and informatics studies with a doctorate in entrepreneurial finance from TUM.

Tommy Vi works on fundraising analysis at UVC. His background includes automotive engineering studies, corporate innovation work and experience in the startup ecosystem.

Veronika Hiebl works on investment controlling, fund reporting and administration. Her background includes business studies, accounting training and experience at a tax consultancy.

Victoria Schaufuss works on investor-relations analysis. Her background includes management and technology studies at TUM and experience at Rigeto and BCG.

Angel Jaramillo was named by Skin2Neuron’s founder as part of an expansion of its executive team in a post discussing its2025 CUREator+ funding. His precise job title is not supplied there.

Skin2Neuron develops regenerative cell therapies intended to replace neurons and rebuild synaptic connections lost in neurodegenerative disease. Its platform isolates, enriches and expands hair-follicle-derived neuroprecursor cells from a patient’s own skin; these naturally occurring cells can differentiate into neurons without genetic modification. Its lead program aims to deliver the cells into the hippocampus to treat Alzheimer’s disease. The company also develops customised neuronal cultures for research, disease modelling and drug testing, and explores applications in other neurological conditions. A University of Sydney spinout, Skin2Neuron has conducted rodent research and a veterinary trial in dogs with dementia. Its human therapy remains in development: a May2026 manufacturing agreement supports preparation for a planned first-in-human Phase1 trial in Australia, rather than an approved treatment. The legal company is Skin2Neuron Pty Ltd, also trading as S2N.

Adam Denley is an external patent attorney at FPA who is named by Skin2Neuron among the advisers managing its intellectual property.

Adam Johnson is Skin2Neuron’s published Head of Laboratory and co-inventor of its technology.

Alyona Mylovanova is published as an administrative consultant on Skin2Neuron’s product-development laboratory page.

Bill Manos is published as a Skin2Neuron director. A lawyer, entrepreneur and investor, he established Manos Capital and helped commercialise Michael Valenzuela’s research.

Brad Sheehan was named by Skin2Neuron’s founder as part of an expansion of its executive team in a post discussing its2025 CUREator+ funding. His precise job title is not supplied there.

Brendon Boot is a neurologist and Skin2Neuron’s CEO. His company biography describes neurology clinical-development experience and joining as CEO in2024.

Dario Gerace is named as a Senior Scientific Officer in Skin2Neuron’s product-development laboratory.

Dawn Driscoll was named by Skin2Neuron’s founder as part of an expansion of its executive team in a post discussing its2025 CUREator+ funding. The post does not disclose her specific rank.

Erica Jacobson is named on Skin2Neuron’s Scientific Advisory Committee with a neurosurgery affiliation at Sydney Children’s Hospital.

Helen Wray is published by Skin2Neuron as acting COO and an expert in chemistry, manufacturing and controls. Her background spans regenerative-medicine commercialisation and technology transfer.

Henry Brodaty is named on Skin2Neuron’s Scientific Advisory Committee with an affiliation at UNSW’s Centre for Healthy Brain Ageing.

Jeffrey Schweitzer is named on Skin2Neuron’s Scientific Advisory Committee with a neurosurgery affiliation at Massachusetts General Hospital.

Kieran Williams is an external FPA patent attorney named by Skin2Neuron among the advisers managing its intellectual property.

Lars Ittner is named on Skin2Neuron’s Scientific Advisory Committee with an affiliation at Macquarie University’s Dementia Research Centre.

Linah Alsaif is named as a Biomedical Engineer in Skin2Neuron’s product-development laboratory.

Manon Levayer is named as a Quality Associate in Skin2Neuron’s product-development laboratory.

Michael Valenzuela is Skin2Neuron’s scientific founder and Chief Scientific Officer. He discovered and developed its hair-follicle-derived neuroprecursor technology. Earlier company biography lists him as CEO; the May2026 joint announcement identifies Brendon Boot as CEO.

Rob McInnes is published as Skin2Neuron’s expert consultant on intellectual-property strategy and commercial deal making. He is principal of Rob McInnes IP Advisory.

Robert (Bob) Deans is named on Skin2Neuron’s Scientific Advisory Committee; its directory describes his previous CTO role at BlueRock Therapeutics.

Russell Knudsen is named on Skin2Neuron’s Scientific Advisory Committee with an affiliation at The Knudsen Clinic.

Sarah Hennebry is an external FPA patent attorney named by Skin2Neuron among the advisers managing its intellectual property.

Sarah Houston is named as Senior Product Development Officer in Skin2Neuron’s laboratory team.

Tim Oldham is published as Skin2Neuron’s expert consultant on cell manufacture and biotech commercialisation. His biography describes cell-therapy manufacturing and life-sciences leadership.

Ernij Next is a Dutch private investment firm described by an investee company as a family office. Its publicly confirmed investments back companies developing industrial technology: autonomous geodetic sensors and data-analysis software at Basetime, AI-powered warehouse picking and palletising systems at Smart Robotics, polymer bonding for diagnostic lab-on-a-chip production at Bondus Technologies, and large-area nanoimprint manufacturing for optical components at Morphotonics. These financings support product development, production scale-up and international commercial expansion. Ernij Next invests alongside specialist venture investors and regional development organisations.

Identified as Ernij Next’s investment manager in Oost NL’s October 2025 announcement of financing for Bondus Technologies. His published statement discusses making medical-product manufacturing technology accessible at scale; other career or legal-name aliases are unverified.

Publicly represented Ernij Next in Basetime’s July 2025 financing announcement, supporting the company’s precision-monitoring products and international growth. The issuer did not publish his exact position or a personal biography.

Bioverge Funds Management LLC is the separate wholly owned Delaware fund-management subsidiary of Bioverge, Inc., formed June 3, 2016 according to the consolidated issuer financial statements. The parent’s own legal disclosures identify it as an exempt reporting adviser registered with California; this is not a claim of SEC registered-investment-adviser status. It manages healthcare investment SPVs, deal-by-deal vehicles and diversified access funds under the shared Bioverge brand. Parent corporate crowdfunding and fund subscriptions are separate financing categories. Direct SEC Form D filings identify Neil J. Littman as Manager of Issuer’s Manager and name Bioverge Funds Management LLC. This dated unit-specific affiliation supports the named public manager core; the parent’s16-person2023 adviser/platform roster is not copied into this legal manager without an employment bridge. The genuine Bioverge brand mark is shared; a separate subsidiary-specific logo is not verified. Four primary SEC legal SPV records disclose actual sold subscription amounts: Notable VI USD325500, NutriSense II USD151093, GigaMune I USD112847 and Contraline II USD124500. Only Notable VI’s filing reports no remaining offering capacity. The others are partial sold snapshots, not verified final fund closes; first-sale and signature dates are not invented exact final-close dates. These subscriptions do not establish an exact cash ticket into a portfolio company or identify the undisclosed Modulo Bio payer vehicle.

Dave Chisholm was named by Bioverge’s own 2023 Republic corporate offering as External Advisor. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

David Stubbs was named by Bioverge’s own 2023 Republic corporate offering as External Advisor. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Joseph Wu was named by Bioverge’s own 2023 Republic corporate offering as External Advisor. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Kevin Coker was named by Bioverge’s own 2023 Republic corporate offering as External Advisor. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Rishav Dasgupta was named by Bioverge’s own 2023 Republic corporate offering as Analyst. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Brenden Boot was named by Bioverge’s own 2023 Republic corporate offering as External Advisor. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Curt Herberts was named by Bioverge’s own 2023 Republic corporate offering as External Advisor. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Greg Simon was named by Bioverge’s own 2023 Republic corporate offering as External Advisor. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Hollis Fullilove was named by Bioverge’s own 2023 Republic corporate offering as Finance & Accounting. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Mark Chao was named by Bioverge’s own 2023 Republic corporate offering as External Advisor. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Luiz Ferreira was named by Bioverge’s own 2023 Republic corporate offering as Engineer & Software Development. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Janine McCargo was named by Bioverge’s own 2023 Republic corporate offering as Media & PR. The campaign explicitly includes people helping build Bioverge beyond employees. This establishes a dated platform affiliation, with current tenure, formal employment and any personal investment not inferred.

Bioverge, Inc. is the Delaware corporate parent of the Bioverge healthcare investment platform, incorporated in August 2017 according to its own issuer campaign; the Bioverge brand and separate fund-management subsidiary began in 2016. Its current own site focuses on early-stage human-health biotechnology, AI-driven drug discovery, neuroscience, genetic medicine, cell therapy, precision medicine and synthetic biology. It gives investors access to deal-specific special-purpose vehicles and diversified access funds. Portfolio and performance statements are the platform’s own commercial claims, not independent clinical or investment-performance validation. The separate wholly owned Bioverge Funds Management LLC manages investment vehicles, while Bioverge Portal LLC has a distinct crowdfunding role. This corporate platform profile does not identify an undisclosed legal SPV as the payer of any branded portfolio investment. The current public about page names Neil Littman as Founder and Managing Partner. Its 2023 Republic offering published sixteen people helping build Bioverge, including external advisers; those dated affiliations are preserved separately without assuming current employment or treating all advisers as employees. Corporate Reg CF financing is separate from cash raised by managed funds. The Republic Crowd SAFE campaign closed August 8, 2023 with USD138,007 from 251 investors. The earlier Netcapital Class B common-stock campaign completed March 1, 2022; its header reports USD708,265, while a March 2 final update calculates USD744,805.89 from shares multiplied by a single price. These inconsistent primary figures are both retained and the earlier round amount remains unknown. Offering maxima, valuation caps, prior aggregate corporate financing and cumulative investment-platform deal volume are not added as new cash rounds.

Neil Littman is Bioverge’s current published Founder and Managing Partner. His own earlier Netcapital biography records business-development leadership at Notable Labs and California Institute for Regenerative Medicine, healthcare investment banking at Thomas Weisel Partners and Deutsche Bank, and biotechnology study at Johns Hopkins. Bioverge’s2023 corporate campaign named him co-founder/CEO. SEC legal SPV filings identify him as manager of the issuer’s manager, Bioverge Funds Management LLC; current corporate and dated legal-manager roles are distinguished.

Rick Gibb was Bioverge’s co-founder and COO in its2023 own corporate campaign. His earlier Netcapital biography records work with Stanford’s venture funds and technology licensing, a Johns Hopkins biotechnology master’s degree and Rice bioengineering study. Current employment is not independently established by the2026 public directory.

Technologist in Residence at Innospark Ventures. His published biography describes MIT Media Lab research into generative AI that helps people understand complex systems, prior aerothermal engineering at Fiat Chrysler, experience design at Infosys, a prototyping studio and early enterprise-AI work at Vianai. It identifies a University of Michigan aerospace engineering degree and an MIT Media Arts and Science master's degree.

Technologist in Residence at Innospark Ventures since 2022, working on machine-learning diligence. His own biography describes internal medicine at NYU Langone and technology leadership at Oatmeal Health, with expertise in healthcare natural-language processing and electronic records. He studied at Yale and holds Harvard MD and PhD degrees.

Current directory card lists Max Krause as Senior Associate, while the biography uses Senior Analyst and Head of Founder Discovery. He leads early founder sourcing, supports diligence and portfolio work, and runs the summer internship programme. His biography says he joined full-time in 2022 after internships in 2020 and 2021 and studied at the College of the Holy Cross.

Current directory card names Jeff Knox as Principal, while the biography calls him a senior investment associate; these published title variants are qualified rather than treated as two positions. His work covers biotechnology and commercial translation, with prior consulting for biopharma and digital health and founding Boston Nucleate leadership. He studied biomedical engineering at Johns Hopkins and holds an MIT Sloan MBA.

Current Innospark directory card lists Brent Willess as Venture Partner; the accompanying biography uses Principal, a source inconsistency retained explicitly. His background includes Founder Collective, Dorm Room Fund and Uber transit strategy, with Virginia Tech undergraduate study and a Yale MBA. Prior-employer investments are distinct from Innospark investments.

Operating Partner at Innospark Ventures. His published biography describes leadership of EnglishHelper, earlier McKinsey and eCredit experience, solar technology entrepreneurship and senior operating leadership at the Clinton Health Access Initiative. His education includes engineering study and an MIT MBA.

Divya Dhulipala is a principal at Haystack. Its current own team page describes investments across stages, capital formation andTheAlignmentSummit, and prior economics study atDuke. SemilShah announced her promotion inSeptember2023; hisApril2026 fundraising post says she leads theNeedles companion strategy and works with limited partners. Her self-published professional profile identifies currentPrincipal affiliation; Forbes’ supplied2026honoree profile includes her authentic named portrait and describes sourced or assisted portfolio work, not personal cash checks. No precise appointment day, unverifieddegree title or individualinvestment ticket is invented.

Aashay Sanghvi joined Haystack in2019 and was publicly promoted to partner inSeptember2023. The firm’s team page describes work identifying investments and helping founders after investment, with economics/history study atHarvard. SemilShah’s2023 announcement names his work onRedpanda,Buf,HausAnalytics andLatchBio. The founder’sApril2026 announcement again calls himpartner, while his current personal website says he is building something new and PreviouslyGeneralPartneratHaystack. His own later self-status is qualified; no invented departure day or unqualified current managerial role. His self-linked Substack author profile supplies the original authentic named portrait, visually inspected.

Barbry McGann joined Workday Ventures in2021 as senior vice president and managing director. Her earlier Workday product leadership covered human-capital and workforce-management applications, following enterprise-software leadership roles at PeopleSoft, Oracle and C3. At Oracle she led CRM product management and operations. She holds a Berkeley MBA and UCLA undergraduate degree.

Caroline Rafferty joined Workday Ventures as portfolio-experience manager in2021 after customer-success work at Workday. Earlier she worked at Showpad and LearnCore, supported startup leaders at the Junto Institute, and interned at Catapult Chicago. She studied communication, writing and entrepreneurship at Michigan.

Michael Magaro oversees Workday corporate development, acquisition integration and Workday Ventures as senior vice president of corporate growth. Earlier he led business finance and investor relations at Workday from2017–2022, following corporate-development/investor-relations work at RetailMeNot and vice-president roles at ServiceSource, Taleo and FormFactor. He studied finance and accounting at San Diego State.

Sarah Ospina leads portfolio experience and belongs to Workday Ventures’ investment team, connecting portfolio companies with Workday business and technical expertise. She previously worked in Workday business development from2013–2018 and spent more than a decade in financial markets, including a principal sales-trading role at Piper Jaffray. She studied business administration at Colorado Boulder.

Savannah Greene joined Workday Ventures’ investment team as principal in2020. Earlier investment roles included Attention Capital and Plexo Capital; her Evercore investment-banking work covered technology transactions and shareholder activism. Before finance she worked in media, including HBO and FOX Networks Group. She holds a Harvard MBA and Stanford international-relations degree.

Atlantic Bridge’s March22,2025 published directory identifies Anne Bautista as Admin Assistant. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Anne is the Office Manager and Executive Assistant in the Palo Alto office. She has been assisting VCs in Silicon Valley for the past 6 years-- organizing schedules, seeing around corners, finding solutions and overseeing everything in between. Prior to this role, she has worn diverse managerial hats in the fields of restaurant operations, pharmaceutical sales and healthcare public relations. When she relocated and lived in Hong Kong for 7 years, she developed and conducted training modules as an advocate for financial literacy. Anne was born and raised in Manila and holds a Bachelor’s Degree in Hotel and Restaurant Administration from the University of the Philippines.

Atlantic Bridge’s March22,2025 published directory identifies Maeve Burke as Executive Assistant. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Maeve joined Atlantic Bridge in 2016. Previously Maeve has worked at Goldman Sachs Dublin, Charles Schwab in San Francisco and supported our Managing Partner, Kevin Dillon, during his MD role at Microsoft European Operations Center in Dublin. Maeve has experience in Executive Assistant and Event Managements roles having worked in the International Labour Office in Geneva, European Commission in Brussels as well as time spent in London and San Francisco.

Atlantic Bridge’s March22,2025 published directory identifies Triona Dunne as Executive Assistant. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Triona is Executive Assistant and Facilities Manager of Atlantic Bridge, Dublin. With more than 25 year's experience as Executive Assistant, she has a proven track record of executive support and management. Triona provides support to Managing Partners Brian Long and Elaine Coughlan, as well as support to General Partner Mark Horgan and the wider team. Previously, she was Executive Assistant to Brian Long, Founder and CEO of Parthus-Ceva Technologies, from 1994-2003. She finds enjoyment in helping people and organisations become successful. Triona successfully project managed the Atlantic Bridge corporate Head Quarter relocation in 2017.

Atlantic Bridge’s March22,2025 published directory identifies Aleksandra Janowska as Trainee Accountant. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Aleksandra is a Trainee Accountant with Atlantic Bridge. Aleksandra has held Finance Positions with Accounting Consultancy and Rhenus Ltd. She holds a Master’s Degree in Economics from the University of Lodz in Poland, and is currently working towards her ACCA Professional Accounting Qualifications.

Atlantic Bridge’s March22,2025 published directory identifies Darragh Cummins as Financial Accountant. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Darragh is a Financial Accountant with Atlantic Bridge, joining in 2024. Darragh is a member of the Institute of Chartered Accountants (Ireland), having trained with PwC’s Asset and Wealth Management Division. Darragh holds a Bachelor of Business degree from DCU.

Atlantic Bridge’s March22,2025 published directory identifies Solveiga Venckute as Financial Accountant. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Solveiga is a Financial Accountant with Atlantic Bridge, joining in 2016. Previously, Solveiga held Assistant Management positions with Meridian Global Services and Lidl GmbH. Solveiga has a Bachelor of Business in Retail Management and is currently sitting her final ACCA exams.

Atlantic Bridge’s March22,2025 published directory identifies Nicola Conroy as Financial Accountant. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Nicola is a financial accountant with Atlantic Bridge. Prior to joining Atlantic Bridge, Nicola was responsible for the Fund Administration and Investor Relations for a boutique investment firm in London. Nicola holds a First Class Honours B. Comm from UCD and is a Fellow of the Association of Certified Chartered Accountants (FCCA).

Atlantic Bridge’s March22,2025 published directory identifies Des Shiels as Financial Controller. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Des is a member of the Institute of Chartered Accountants (Ireland), having trained with KPMG’s financial services division in Dublin, where he took lead roles in the audit of clients in the banking and aircraft leasing sectors. He then headed up the management accounting division in Dublin-based outsourcing firm Contract Accounting, where he provided financial control and mentoring advice to startup and SME clients in the retail and services sector. This was followed with a spell in Aviva as management accountant in their Investment Management department (AIME). Des holds an honours masters degree in Accounting from DCU, having completed a BA in Accounting and Finance from the same institution.

Atlantic Bridge’s March22,2025 published directory identifies Megan Quenet-Meintjes as Legal Advisor. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Megan joined Atlantic Bridge in 2020 as Legal Counsel. She focuses on providing legal expertise during the evaluation and execution of new investments, as well as legal support to Atlantic Bridge’s portfolio companies. Prior to joining Atlantic Bridge, Megan worked as a lawyer at Cliffe Dekker Hofmeyr, a leading South African law firm, where she specialised in Mergers & Acquisitions submissions and restrictive trade. Megan holds a BA and LLB from the University of Cape Town, as well as a Master’s degree in Law from the University of California, Berkeley, specializing in Venture Capital, Mergers & Acquisitions and Antitrust.

Atlantic Bridge’s March22,2025 published directory identifies Carl Jackson as Senior Advisor. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Carl Jackson has an Electronics Engineering background, completing a PhD after immigrating to Ireland in the late 90s. Carl spun-out the semiconductor sensor technology from his PhD into SensL promptly spending the next 14 years building a fantastic team, products and brand to become the leading sensor supplier in markets from medical imaging to automotive. SensL was purchased by Onsemi in 2018. Carl was VP Engineering at Onsemi for 3 years before exiting the business to focus on startups as an entrepreneur. Carl currently engages with an exciting group of startups and SMEs investing, advising and as an active participant as needed to assist each in moving forward rapidly to build shareholder value and realize their full potential. Carl has strategically advised companies from founding, funding, growing, operating to exiting. In Carl's last exit in 2023 he operated as banker and seller's rep, realizing the sale of the high tech start-up to that industry's NASDAQ listed market leader. Carl works with Atlantic Bridge as Strategic Advisor from his home base in Cork particularly involved with his alma mater, UCC and Tyndall to encourage the next generation of spin-outs.

Atlantic Bridge’s March22,2025 published directory identifies Brendan Cremen as Senior Advisor. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Brendan Cremen has an engineering background and has been active in technology and business innovation throughout his career. In the 1980s, he was a member of the start-up team at Lattice Semiconductor in the US and held senior engineering and business management roles there through to IPO. On returning to Ireland in the mid-1990s, Brendan joined the launch team for Xilinx Ireland where he led the expansion of its mandate as an international R&D hub for the corporation. More recently, he spent 10 years in the development of the commercialisation agenda within the Irish university sector, most directly with UCC and UCD. At UCD he drove the establishment of the University Bridge Fund and now is an advisor to this fund.

Atlantic Bridge’s March22,2025 published directory identifies Augustine Syn as Senior Advisor. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Augustine has 30 years of business experience working with C-level executives and senior government officials in Europe, the US and Asia, and across multiple industry sectors such as Aerospace & Defence, Environmental Engineering, Oil & Gas and Information & Communications Technology. From 2007 to 2021, Augustine was the Senior Vice President (Europe) based in London for Singapore-listed ST Engineering, a Temasek-linked company. In addition to developing new opportunities in Smart Cities and Urban Transportation, he was involved in the €250m acquisition of a satellite communications company and a strategic co-investment with Atlantic Bridge in Cloudsphere. Prior to ST Engineering, Augustine was a Defence Counsellor for 5 years at the Singapore Embassy in Paris, where he oversaw strategic cooperation agreements between Europe and Singapore. Augustine holds a Master’s degree in Photonics Engineering (1989) from France, where he studied on a Singapore government scholarship. In 2001, he was sponsored by the Singapore government to attend the INSEAD Asian International Executive Programme. More recently, he obtained an MIT Professional Certificate in Quantum Computing in 2018 and has given talks on the subject. Augustine remains a Non-Executive Director of ST Engineering in the UK and is also the Non-Executive Chairman of Insight Terra, a portfolio company of Atlantic Bridge.

Atlantic Bridge’s March22,2025 published directory identifies Jennifer Westrup as Life Sciences Advisor. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Dr. Westrup is the Director of Oncology, and a Consultant Medical Oncologist at Beacon Hospital Dr. Westrup is appointed Associate Clinical Professor at University College Dublin and sits on the steering committee of the innovative UCD Beacon Academy. Dr. Westrup is the former Medical Director at Beacon Hospital. Dr. Westrup was a member of the original Beacon Hospital Board from 2007 – 2008, served as Chairperson of the Beacon Pharmacy/Therapeutics Committee for 3 years, and as the Director of Education for Beacon Hospital from 2008 – 2014. She currently sits on the Clinical Governance Committee of the Beacon Hospital Board, and was an invited member of the International Quality and Patient Safety Committee of UPMC. Dr. Westrup lectures on the UCD Risk Management Program. Dr. Westrup is a member of Cancer Trials Ireland. Her past research on breast cancer has been presented at international conferences, and is published in peer reviewed journals. Dr. Westrup currently advises the Health Care Products Regulatory Clinical Sub Trials Committee. She is a member of the National Cancer Care Program, Melanoma Clinical Advisory Group. Dr. Westrup graduated Cum Laude from Wake Forest University with a BSc in Biology and received her medical degree with honours at University College Dublin. She completed an Internal Medicine Residency at Boston University Medical Center, was Resident Teacher of the Year and awarded the CREST scholarship; a National Institute of Health Grant. She completed a fellowship in Hematology/Oncology at Boston University Medical Center and was honoured as Chief Fellow. Dr. Westrup is American Board Certified in Internal Medicine and Medical Oncology.

Atlantic Bridge’s March22,2025 published directory identifies John Hearne as Senior Strategic Advisor. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. John Hearne joined Atlantic Bridge as a senior strategic advisor and investor in 2016. John co-founded Cúram (provider of software to help government agencies administer social welfare and health services) which was acquired by IBM in 2011. He served as Cúram Software’s CEO, successfully overseeing its growth into one of the leading providers of HR & GovTech Software. Expertise in enterprise software, GovTech, SaaS & scaling.

Atlantic Bridge’s March22,2025 published directory identifies David Lam as Senior Advisor. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. David Lam is a Senior Advisor of Atlantic Bridge Capital. He led the firm’s investments and represents Atlantic Bridge on the boards of Semsysco, SweGaN, Caption Health, Syntiant and AtScale. He previously represented the firm on the boards of Movidius (acquired by Intel), Decawave (acquired by Qorvo) and Navitas (Nasdaq IPO), among others. Prior to Atlantic Bridge, David was Managing Director of WestSummit Capital where he served as its representative on the boards of Twitch (acquired by Amazon), Mirantis and Maginatics (acquired by EMC) among others. David was previously Managing Director for WI Harper, a cross-border venture capital firm. Prior to that, David was Vice President at The Carlyle Group, a global private equity firm, after serving as head of business development for a Carlyle portfolio company. He also held various operating roles at CIENA Corporation, ONI Systems, Cisco Systems and Proxim. David began his career as an investment banker at Robertson Stephens & Company. David is a board member, past president and past chairman of the Asia America MultiTechnology Association (AAMA), which is the oldest and largest pan-Asian, cross-border technology executive network in Silicon Valley. He also serves on the boards of the Association of Asian American Investment Managers (AAAIM) and the Bullis-Purissima Elementary School Foundation. David holds a BS and an MA from Stanford University, and an MBA from the MIT Sloan School of Management where he was recipient of the Merit Scholarship and Patrick McGovern Award.

Atlantic Bridge’s March22,2025 published directory identifies Thomas Alt as Venture Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Thomas is an experienced entrepreneur with a demonstrated history of working globally in the software and consumer electronics industry. Atlantic Bridge invested in Metaio in 2012, an AR software company which Thomas founded and which was acquired by Apple in 2015. From 2015 – 2018 Thomas was based at Apple HQ Cupertino USA where he was Director of Engineering as well as Director of Procurement in the Strategic Deals Team. Thomas is highly skilled in Augmented Reality, Entrepreneurship and Strategic Partnerships and leads dealflow in key sectors like AR/VR, Automotive, Software.

Atlantic Bridge’s March22,2025 published directory identifies Helen Ryan as Operating Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Helen Ryan was the Chief Executive Officer of Creganna-Tactx Medical from 2005 until September 2013. Creganna-Tactx Medical is a global supplier to the medical device industry specialising in products, technologies and solutions for minimally invasive therapies. The company is currently ranked among the world’s top 10 medical device outsource providers. During Helen’s time as CEO, the company grew five-fold to become the largest indigenous medical device company. The expansion included three company acquisitions, a strategic joint venture in Asia, and the raising of significant debt and equity financing. The organisation grew from 100 people at a single site in Galway to over 1,250 people across a global network of four sites in Ireland, the USA and Singapore. Prior to joining Creganna-Tactx in 2003, Helen worked with Medtronic and Tyco Healthcare (Covidien) in Product Development and R&D functional management roles. Helen has a Bachelor of Engineering from NUI Galway, a Masters in Project Management from UL, and has completed a Senior Executive Programme at Stanford University. Helen is a fellow of the Institute of Engineers of Ireland, a past Chair of the Irish Medical Devices Association, and serves as a non-executive director of a number of companies.

Atlantic Bridge’s March22,2025 published directory identifies Joe Macri as Operating Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Joe Macri joined Atlantic Bridge as a Senior Advisor in 2021 and has 35 years’ experience in the technology sector, including 24 years at Microsoft in various international leadership roles. At Microsoft, Joe was responsible for establishing the UK SMB business, creating and leading the Irish Subsidiary, launching the commercial cloud business in Western Europe, leading Microsoft’s EMEA Public Sector business and, most recently, leading the UK Partner Business as they created new AI capabilities and accelerate their transformation to the cloud. Prior to Microsoft, Joe worked at NatWest and before that he worked for a number of technology companies in Australia. Joe holds an MBA from Warwick Business School in the UK and a Computer Science Bachelor of Science degree from Sydney University. He took up sailing several years ago crewing on a Grand Soleil and when not spending time with his family, he enjoys cycling.

Atlantic Bridge’s March22,2025 published directory identifies Jonny Halmer as Investment Associate. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Jonny joined Atlantic Bridge in 2023, where he focuses on sourcing, evaluating and executing new investments. Prior to joining Atlantic Bridge, Jonny worked within the M&A team at One Retail Group, a multi-national ecommerce brand owner. Before this, Jonny founded his own ecommerce brand whilst studying at university, which he sold in 2021. Jonny holds a BSc First Class degree in Industrial Economics from the University of Nottingham.

Atlantic Bridge’s March22,2025 published directory identifies Weili Wang as Senior Investment Associate. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Weili joined the University Bridge Fund in 2021. Prior to joining Atlantic Bridge, Weili was a Biotech Investment Fellow at M Ventures, the venture capital arm of Merck KGaA. Before entering the venture capital world, Weili gained experienced across roles in the University of Queensland Technology Transfer Office, KPMG, as well as in Independent Innovation Centres. Weili holds two Master's degrees in Molecular Biology & Technology and Innovation Management from University of Queensland.

Atlantic Bridge’s March22,2025 published directory identifies Dominik Leisi as Investment Manager. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Dominik joined Atlantic Bridge as a Senior Investment Associate on the University Bridge Fund in 2022. Prior to joining Atlantic Bridge, Dominik was an Investment Manager in the Life Science Team of the University College London (UCL) Technology Fund which is managed by Albion Capital. Before joining the UCL Technology Fund, Dominik was responsible for the commercialisation of technologies that originated at the UCL Cancer Institute and the UCL GOSH Institute of Child Health. He has also held different R&D roles within the medical device and speciality pharmaceutical industries. Dominik holds a BSc in Life Sciences Technologies from the University of Northern Switzerland and a MSc in Innovation and Management from Imperial College Business School.

Atlantic Bridge’s March22,2025 published directory identifies Senan O'Mahony as Investment Manager. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Senan is an Investment Manager at Atlantic Bridge, having joined in 2021, where he focuses on sourcing, evaluating and executing new investments. Prior to joining Atlantic Bridge, Senan worked at Bank of Ireland and was involved in the structuring and execution of leveraged finance transactions in the Irish market, as well as managing Bank of Ireland’s participation as a limited partner in a number of venture capital and private equity funds. Senan holds a BA, BAI and MAI in Biomedical Engineering from Trinity College Dublin, a Diploma in Financial Advice (QFA) from the Institute of Banking and has passed Levels I and II of the CFA Program.

Neurolieve Biosciences is a London biotech developing NLV-01, an investigational biologic for peripheral neuropathic pain. Its bioengineered fusion protein is designed to selectively activate galanin receptor2 (GalR2) in peripheral nerves, aiming to provide pain relief and support nerve repair. The company describes a design that keeps the protein outside the brain to avoid central nervous system effects; these are development goals and preclinical findings, rather than proven clinical outcomes. The lead programme initially targets chemotherapy-induced peripheral neuropathy, with potential expansion into diabetic neuropathy and other peripheral pain conditions. The company reports that discovery and lead selection are complete, preclinical validation is in progress, IND-enabling work is the next milestone and clinical development remains future work. Its own footer explicitly states that NLV-01 has not been approved by any regulatory authority. Neurolieve was co-founded with NLC and LifeArc and develops technology originating from LifeArc’s collaboration with University of Bristol pain researcher David Wynick. NLC provides venture-building support and backing; LifeArc contributes protein engineering, licensed commercial rights and continuing laboratory collaboration.

Atlantic Bridge’s March22,2025 published directory identifies Conor O'Sullivan as Investment Director. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Conor joined Atlantic Bridge in 2021 where he focuses on identifying and evaluating new investment opportunities for the University Bridge Funds. Prior to joining Atlantic Bridge, Conor was based in London where he was Vice President at Paladin Capital, one of the most active early-stage venture capital investors in the cybersecurity sector. Before Paladin Conor was Investment Manager at Seraphim Capital, the largest investment group dedicated to investing in space technology start-ups. Following his MBA at the University of Oxford, Conor joined the Satellite Applications Catapult, a space research and technology centre funded by the UK Government, as Head of Business Strategy supporting over 100 start-ups. Prior to this Conor worked in sales, trading and operational roles for 5 years at two global investment banks. Conor holds an MBA from the University of Oxford and a BA in Business and Economics from Trinity College Dublin.

University of Bristol molecular medicine professor and pain consultant, scientific adviser and co-inventor behind Neurolieve’s GalR2 programme.

NLC analyst with a neuroscience background whom Neurolieve explicitly identifies as its representative at a pain therapeutics summit. Exact Neurolieve job title and employment status are unverified.

Neuroscientist and molecular pharmacologist, LifeArc’s published Director of Preclinical Science, and scientific adviser and co-inventor for Neurolieve’s programme.

NLC-affiliated professional whom Neurolieve explicitly identifies as its representative at a pain therapeutics summit. Exact Neurolieve job title and employment status are unverified.

Life-science entrepreneur and Neurolieve’s published co-founder and earlier chief executive. Official filings record his company directorship from February5,2024 until resignation on December21,2025. The precise CEO transition date is unpublished.

Physician and drug-development specialist leading Neurolieve’s scientific programme, with published experience in neurology, pain and emergency medicine.

Atlantic Bridge’s March22,2025 published directory identifies Melissa Yvonnou as Investment Director. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Melissa joined Atlantic Bridge in 2020 as Investment Director Europe. She is based in our Paris and London offices and focuses on venture to growth investments in software across Europe. Melissa has more than 10 years’ experience in VC and growth investment in the UK, France and Spain – she is a French national with Spanish family, who has lived and worked in the UK for several years. Prior to joining Atlantic Bridge she worked for Ardian as a member of the Growth team. Melissa graduated with a MSc in Mathematics and Computer Sciences from Ecole Nationale Supérieure d’Informatique et Mathématiques Appliquées in France.

Atlantic Bridge’s March22,2025 published directory identifies Paul Murray as Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Paul joined Atlantic Bridge in 2012 and brings over 14 years’ operational experience in the Semiconductor industry. Prior to Atlantic Bridge, Paul spent 11 years in various engineering and management roles in the semiconductor industry. He worked for global companies as well as start-ups, including Analog Devices, Parthus, and Phyworks. At Analog Devices he led the development of fiber-optic communications products. Paul was also a key member of Chipsensors, an Irish fabless start-up developing environmental sensing devices, which was acquired by Silicon Laboratories in 2010. Paul holds a First Class Honours degree in Electronic Engineering from University College Dublin and a Masters in Management from the Smurfit Business School, University College Dublin and is the holder of a number of US patents. He is a Kauffman Fellow having completed the program in Palo Alto, California as a member of Class 17 in 2014. An avid outdoor enthusiast, Paul participates in many outdoor acivites such as hiking and orienteering and volunteers as a Mountain Ranger in the Dublin Mountains.

Atlantic Bridge’s March22,2025 published directory identifies Peter McManamon as Chairman. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Peter co-founded Parthus Technologies plc (now CEVA Inc.) in 1993. He was Chief Financial Officer from 1993 to 2001 and EVP, Corporate Development responsible for significant merger and acquisition activity from January 2001 to October 2002. He is currently Chairman of the board of directors of CEVA Inc., a NASDAQ listed company. From 2003 - 2013 Peter was a member of the Board of the National Development Finance Agency (NDFA), an appointment made by the Irish Government and was also a member of the Audit Committee at the National Treasury Management Agency (NTMA). Peter is a member of the Governing Board of Technology Ireland. Peter is a Chartered Director and a member of the Institute of Directors in Ireland and a former Business Advisor on the Stanford University Executive Program, Strategic Leadership for CFOs, which was funded by Enterprise Ireland.

Atlantic Bridge’s March22,2025 published directory identifies Gerry Maguire as General Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Gerry is a Co-Founder and General Partner at Atlantic Bridge and is an experienced Investor, Executive and Design Engineer with a thirty-year career in the technology industry. Prior to joining Atlantic Bridge, he was Vice President R&D at Parthus Technologies responsible for managing a business which included divisions in Ireland, UK and USA. Gerry joined the company in 1993 and played a key role in its transition from startup to successful IPO on Nasdaq. Gerry also held senior management roles at several technology companies including Philips and Texas Instruments. Gerry has a BA, BAI degree in Electronic Engineering from Trinity College Dublin and a Diploma in Company Direction from the Institute of Directors.

Atlantic Bridge’s March22,2025 published directory identifies Kevin Dillon as Managing Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Kevin is Co-Founder and Managing Partner at Atlantic Bridge and has 30 years’ operating experience in the technology sector, including a total of 13 in Paris, London and Dublin as an executive in the software industry and five years in Silicon Valley. Kevin served as Vice President, Microsoft EMEA and helped grow the regional business from $500 million in 1991 to $9.5 billion in 2004. At Microsoft, Kevin was a member of Microsoft EMEA’s senior management team responsible for various roles in Finance, Operations, and Sales and Marketing including establishing the European Operations centre in Dublin. Kevin is a frequent industry speaker and was ICT Ireland Industry Person of the Year in 2001 and elected a fellow of the Irish Management Institute in 2000. He holds various degrees in Business, Finance, Taxation & Law and is an Attorney at Law, Certified Public Accountant and Certified Investment Manager.

Atlantic Bridge’s March22,2025 published directory identifies Mark Horgan as General Partner & CFO. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Mark is Co-Founder, General Partner & CFO at Atlantic Bridge. Prior to this, Mark was CEO of Mentor Capital, a venture capital firm he founded in 2001 that specialized in investing in and mentoring seed and early stage technology companies. Mark has a successful track record of investing in and growing technology companies and has sold numerous companies, including OMI, Firecomms and Nanotech, to international buyers since 1997. Mark was also previously the Group Financial Director of Mentec Limited, an established Irish enterprise software company where he executed a number of merger and acquisition deals including a partial exit for shareholders. Mark was Chairman of the Irish Venture Capital Association (IVCA) from June 2013 to June 2014. He holds a B. Comm from University College, Cork and an M.B.A. from University College, Dublin. In addition, Mark is a Fellow of the Institute of Chartered Accountants in Ireland.

MindAffect is a Dutch neurotechnology company developing objective hearing and vision assessments from automatic brain responses. Its Sofi Hearing Assessment System uses an EEG headset and its Rapid-CAEP cortical-response analysis technology to estimate frequency-specific hearing thresholds without requiring patients to speak, press a button or follow behavioral testing instructions. The approach is intended for children and people with communication or cognitive difficulties. MindAffect also develops KinderCap, KinderGaze and GLAM vision-assessment concepts using controlled visual stimuli, EEG and, in some designs, eye tracking. The company spun out of Radboud University’s Donders Institute with NLC in 2017. Its current site states that Sofi and Rapid-CAEP remain under development and are not certified for clinical diagnostic use. MindAffect reports FDA Breakthrough Device designation for Sofi in January 2026; this is a development pathway designation, not FDA marketing clearance.

Andy Beynon advises MindAffect on auditory diagnostics. The company identifies him as Head of the Vestibular and Auditory Evoked Potential Lab at Radboud UMC.

Harry van Dorenmalen was appointed chairman of MindAffect’s supervisory board in July 2022. The announcement describes his prior leadership at IBM Europe and his business and technology governance experience.

Ida Reinds is Communication Engineer at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Jennifer Goodall is CEO at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Luc Nijssen is Lab Manager at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Maria Bikikou is Software Engineer at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Mark van Kesteren is Chief Technology Officer at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Marten de Vries is Head of Software at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Marzieh Borhanazad is Head of Product Compliance at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Mohamed Hassan is Intern at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Mona Dworsack-Dodge is an audiologist and market development professional named among MindAffect’s advisers.

Oscar Portoles is Chief Scientific Officer at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Peter Desain is a founder of MindAffect whose brain-computer-interface research at Radboud University’s Donders Institute underpins the company’s technology. His 2024 scientific publication discloses his MindAffect founder affiliation; a current operating or advisory title is not established.

Rees Wilson is Head of Manufacturing at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Rohit Vijayakumar is R&D Engineer at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Saskia Vulliez-Sermet is Head of Business Development at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Simon Bambach joined MindAffect’s supervisory board in July 2022. The announcement describes his high-technology venture-building experience, including Simotec and Carbyon, and earlier work at VDL and Philips.

Tanja Claasen joined MindAffect’s supervisory board in July 2022. The announcement describes her high-technology business leadership and physics and electronics training; its Robin Radar role is dated career context.

Thijs Thielemans advises MindAffect. The company identifies his background as an audiology medical physics expert at Hoortoestel Advies Centrum.

Timothé Guyonnet-Hencke is R&D Engineer at MindAffect, which develops brain-response technology for objective hearing and vision assessment.

Atlantic Bridge’s March22,2025 published directory identifies Elaine Coughlan as Managing Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Elaine is a Founder and Managing Partner of Atlantic Bridge and has 30 years of experience in industry as a founder, executive and investor scaling technology companies including Movidius (Acquired by Intel), and Decawave (Acquired by Qorvo). She successfully led three Nasdaq IPO’s creating €5bn in shareholder value for Parthus, Iona and Smartforce. She was a co-founder of Glonav a GPS semiconductor company (Acquired by NXP). Elaine was appointed by the Irish Government to the Board of Enterprise Ireland (2014-2022) and appointed by the UK Government (2022-Current) to British Patient Capital’s £800m Future Fund Breakthrough investing in UK companies in Biotech, Quantum, AI, Cyber Security and sectors of strategic importance. She is a Board member of Irish Life Health which is part of Canadian Group Great West Life Co with $1 trillion assets under management and a former board member of CPL plc (Acquired by Outforce Group Japan). Elaine has been named one of Forbes Europe 50, Europe’s Top 50 Inspiring Women in Technology and awarded the 2023 Outstanding Contribution to Industry by Chartered Accountants Ireland. Elaine has a MSc in Corporate Governance, is a Fellow of the Institute of Chartered Accountants and a qualified Chartered Director.

Atlantic Bridge’s March22,2025 published directory identifies Brian Long as Managing Partner. This is a dated published affiliation; current tenure is not independently confirmed by the redesigned live site. Brian has over 30 years experience in the Semiconductor and technology industry and is based in Palo Alto California. In 1993, Brian was founder and CEO of Parthus Technologies Plc (now CEVA Inc), a leading Digital Signal Processing company which supplied technology and IP to over 40% of the world’s smart phones. In 2000, Brian led the company’ Initial Public Offering with a dual listing on the Nasdaq and LSE stock markets. In 2002 Brian founded and was chairman of GloNav Inc, a leading GPS company which developed the first single chip GPS solution deployed in the Samsung Galaxy phones. The company was sold to NXP in 2004. Brian is co-founder and Managing Partner of Atlantic Bridge Capital from 2004 to present time. During that time, Brian has served as a director on over twenty technology companies in Europe and the US and was instrumental in helping build and successfully sell these companies, principally to major US corporations. These BOD/Chair roles include:- Movidius sold to Intel, DecaWave sold to Qorvo, Magnetics sold to Dell/EMC, Blue Data sold to HPE, Nanotec sold to Gennum Inc, Bridge Co sold to SMSC, Silicon Blue sold to Lattice Semi, Lion Semiconductor sold to Cirrus Logic, Hedvig Inc sold to Commvault, Nod Labs sold to AMD, NuVia sold to Qualcomm, Chirp sold to TDK and Navitas (NVTS) IPO on Nasdaq. Brian has an undergraduate and Master's degree in Electronic Engineering and Semiconductor MicroElectronics from Trinity College Dublin. Brian started his career as a design engineer at Bell Labs AT&T and later as Corporate head of mixed signal IC design at Digital Equipment Corporation. He is cited as the inventor on a number of US and European IC patents. Brian was awarded the Earnest&Young Entrepreneur of the year award in 2000, Silicon Valley Top 50 Technology Executive in 2010 and was awarded the American-Ireland Fund Person of the year Award in 2014.

David DiDomenico is named in a current Neros announcement reproduced on COO Sean Wood’s public profile as newly joining the company as VP of Operations. The announcement describes previous production and supply-chain responsibility at Astranis and SpaceX programmes including Starlink. Exact appointment day and a verified authentic portrait are unpublished in the sources inspected; no broader education or career history is inferred.

Earl G. Matthews is identified in Neros CEO Soren Monroe-Anderson’s May2024 primary account as an early employee leading business development and legal. That source also describes earlier NationalSecurityCouncil senior-director and acting USArmy general-counsel responsibilities. The Neros affiliation is explicitly historical2024, with no current2026 employment claim, exact tenure dates or personal investment inferred. An authentic headshot remains a documented gap.

Felix Pomerantz’s own public professional profile identifies Neros Technologies as his company and discusses leading hiring and scaling across finance, legal and business operations. The inspected primary profile does not disclose a reliable exact current job rank, so no CFO or director title is assigned. His professional affiliation does not imply an individual financing check; authentic portrait and appointment day remain unverified.

Phil Alden is named in a Neros announcement reproduced on COO Sean Wood’s public profile as a Senior Advisor. The issuer describes previous SpaceX leadership in Starship production and Starlink user-terminal manufacturing. This is an external advisory capacity, distinct from ordinary staff employment, management authority or a disclosed personal investment. Exact appointment date and authentic headshot are not verified.

Sean Wood is identified as COO in Neros’ own public professional post. The CEO’s May2024 primary account previously described him as Head of Hardware, following12years at SpaceX across Falcon9 and Starlink manufacturing. These are separately dated professional capacities; the exact COO appointment day is unpublished. His own profile confirms continued Neros affiliation, but no authentic verified headshot has been added.

Olaf Hichwa is co-founder and CTO of Neros according to its own SAE sponsorship announcement. The founders’ primary2024 account describes designing and selling drone electronics from his teenage years and putting college on hold to co-found Neros in2023. His individually named authentic photograph is the original Neros-hosted interview thumbnail, not the drawn avatar on an investor profile.

Soren Monroe-Anderson is co-founder and CEO of Neros, as identified in its August2026 official financing release. His own founder account describes professional drone racing, winning the2020 MultiGP world championship and operating a drone-component business before founding Neros with Olaf Hichwa in2023. His current role is distinct from any personal investment claim. The authentic image is the original individually named interview-thumbnail photograph published on Neros’ mission page, including its original graphic context.

Edmund P. Harrigan, MD, is a Modulo Bio board director, announced July2,2025 and independently confirmed by Acadia’s current biography. A former practicing neurologist, he held Pfizer leadership roles in worldwide safety, regulatory affairs, business development and neuroscience. He earned his MD at the University of Massachusetts and completed neurology training at Boston University. His experience includes guiding clinical development and regulatory interactions for neurological therapeutics. Acadia and Incyte public biographies do not publish an authenticated personal portrait on their current pages.

Karissa Laskarides publicly identifies Comulate as her employer and appears in the company’s public employee listing. Her professional profile lists New England College of Business and participation in the company’s customer community and BALANCE event. The accessible first-person sources do not expose her detailed current job title; secondary customer-success and prior operations titles are not substituted as confirmed current company positions.

Sahil Verma co-authored Comulate’s SQL context-engineering article with Graham McAlister. His own professional profile identifies a machine-learning engineering background, Comulate affiliation and study at the University of Wisconsin–Madison. His published work at Comulate concerns scalable agent-context retrieval over structured business data. Other unrelated professionals named Sahil Verma are not inferred to be this person.

Graham McAlister co-authored Comulate’s technical article on using SQL as an agent-context interface with Sahil Verma. His own professional profile identifies work at Comulate and his transition to an AI Engineer title, with a background as a data generalist and study at the University of North Carolina at Chapel Hill. The company article covers retrieval, search and schema design for business-data agents.

Gavin Fogel is publicly identified as an Engineer in Comulate’s document-understanding article. He authored its technical description of a self-learning retrieval-augmented-generation pipeline for extracting structured data from insurance invoices, including document-format identification, remittance context and evaluation against pure language-model approaches. The role is supported by the company’s published author attribution; a similarly named Penn State kinesiology student is not assumed to be this individual.

David Dickson is Director of Partnerships at Comulate, as published in its current team section. His own accompanying statement describes nearly a decade of insurance-industry experience and his decision to join the company after observing customer enthusiasm for its product. His affiliation concerns company partnerships and is distinct from outside broker executives quoted as customers.

Mae Heitmann is a Software Engineer publicly featured by Comulate. Her first-person company statement emphasizes direct engineering collaboration with customers and rapid delivery of features. She co-authored the company’s PostgreSQL performance article with Andrew Arnold, explaining cache effectiveness, indexing and workload tuning for insurance data infrastructure.

Andrew Arnold is a Software Engineer publicly featured on Comulate’s current company page. His own published team statement describes choosing the company for product, growth and learning opportunities. He co-authored Comulate’s technical account of PostgreSQL cache optimization with Mae Heitmann, covering database performance for large insurance-policy and transaction workloads.

Michael Mattheakis is co-founder and CTO of Comulate. The founders’ own account describes his prior engineering work at Brex and the team’s pivot into insurance accounting automation. His self-published professional profile lists the University of Michigan; a first-person testimonial published by his recruiting partner identifies his CTO title and work building the engineering team. These sources are distinguished from a different Michael Mattheakis associated with Cretan Medicare in Greece.

Natalie Sandman Krey joined Comulate as Chief Operating Officer in 2025, according to her own announcement and the company CEO’s corroboration. Previously a General Partner at Spark Capital, she led its investment in Comulate’s seed financing and supported the company before taking an operating role. Her first-person account traces her interest in insurance workflow automation to hands-on benefits-enrollment work at Zenefits. Prior portfolio-company involvement is historical and does not establish current employment, continued board tenure or personal investment checks.

Jordan Katz is co-founder and CEO of Comulate, legally Ardent Labs, Inc. He and Michael Mattheakis built the company after working in technology; their own founding account describes pivoting from software for SaaS companies to the manual accounting workflows of insurance brokers. His public professional profile lists the University of Michigan Ross School of Business and a computer-science minor. His work centers on insurance operations automation and building partnerships with brokers. His own announcement identifies Natalie Sandman Krey as the investor who led Comulate’s seed financing while at Spark Capital, before joining the company as COO.

Comulate is a San Francisco AI software company serving insurance brokers and agencies. Its legal entity is Ardent Labs, Inc., doing business as Comulate. Founded in 2022 by Jordan Katz and Michael Mattheakis, it develops accounting automation and revenue intelligence for direct billing, statement reconciliation, carrier payables, cash application, commission recovery and related insurance operations. Its engineering publications describe self-learning retrieval-augmented generation for extracting invoice data and SQL-based context retrieval for AI agents. The founders previously worked in technology and pivoted into the manual workflows of insurance accounting. Jordan Katz leads the company as CEO, Michael Mattheakis is co-founder and CTO, and Natalie Sandman Krey joined as COO in 2025 after investing through Spark Capital. Other publicly named operators and technical contributors are recorded with source-qualified roles. On February 11, 2025 the company announced a USD20 million Series B co-led by BOND and Workday Ventures. Earlier backing is described separately from this financing: published cumulative funding and portfolio cards do not establish additional single-round cash. Crystal Venture Partners labels its relationship a pre-fund investment, while the issuer names Jonathan Crystal personally among prior investors.

Published in ROM Utrecht Region’s 2025 annual report as supervisory board member; audit committee chair. The report was signed in June 2026; subsequent continuation and outside appointments have not been assumed.

Published in ROM Utrecht Region’s 2025 annual report as chair of supervisory board; remuneration committee member. The report was signed in June 2026; subsequent continuation and outside appointments have not been assumed.

Published in ROM Utrecht Region’s 2025 annual report as supervisory board member; remuneration committee chair. The report was signed in June 2026; subsequent continuation and outside appointments have not been assumed.

Former supervisory board and audit committee member of ROM Utrecht Region. The firm’s own appointment announcement explicitly confirms his departure; the exact last day is undisclosed.

Published in ROM Utrecht Region’s 2025 annual report as supervisory board member; vice-chair. The report was signed in June 2026; subsequent continuation and outside appointments have not been assumed.

Dutch public-sector leader appointed to the supervisory board of ROM Utrecht Region effective January 1, 2026. The firm’s own appointment announcement describes her governance and supervisory experience and her role as acting mayor of Wijk bij Duurstede at that time; later mayoral office status has not been checked.

Cesar Levene is a general partner in Myelin VC’s current published team directory. The firm links his own professional profile, providing the exact identity and current manager affiliation. An indexed primary SEC adviser disclosure also names Cesar Levene Areco as a shareholder of Myelin II Management LLC, but the complete current ADV was inaccessible; that indexed legal-name lead is not used to invent additional appointments or new company financing. A longer verified public career biography remains a research gap.

Catalina Plorutti is chief financial officer at Myelin VC, as identified by the firm’s own team directory and linked professional profile. Her professional profile associates her education with Universidad Torcuato Di Tella and documents an international work history spanning Argentina, Hungary and the United States. The published manager role establishes her finance responsibility; the available public sources do not disclose detailed fund-accounting responsibilities or appointment dates. A differently linked Amrop namesake profile is excluded.

Milos Fulton is a venture partner at Myelin VC. Reality Defender’s own team biography identifies him as its chief operating officer and describes more than fifteen years of experience in technology and private capital. It documents earlier operations, fundraising and investor-relations work at Gameto, Overture Life and Goggo Network, earlier investing at Jazzya Investments, and education at IE Business School and CUNY Hunter. The same primary biography independently corroborates his Myelin venture-partner affiliation.

Gaston Maffei is listed as principal in Myelin VC’s current own team directory. His public professional profile describes him as a physicist turned investor and uses General Partner as its current self-title, while the manager website continues to publish Principal. Both source-specific descriptions are retained without an invented promotion date or treating the website as evidence of a current general-partner appointment. His profile associates his education with Universidad de Buenos Aires.

Federico Jack is an investment partner at Myelin VC. His self-published professional profile describes more than twenty years of experience building and managing technology teams. The Deep Digital conference organizer describes earlier operations work at Southworks, Auth0 and Satellogic and investment/advisory activity in Argentina. Those career affiliations do not establish that Myelin itself funded every company he previously worked with.

Alec Oxenford is listed as non-executive general partner at Myelin VC. Argentina’s own embassy biography identifies Alejandro “Alec” Oxenford as ambassador to the United States and describes his entrepreneurship at DeRemate, OLX and letgo, earlier Boston Consulting Group work, Harvard MBA and Argentine business-administration education. The embassy also explicitly identifies investing through Myelin Venture Capital. The non-executive qualifier is preserved rather than implying a full-time operational venture role.

Martin Varsavsky is a general partner at Myelin VC and an Argentine-Spanish entrepreneur and investor. His own published biography describes a career founding telecommunications and internet businesses including Viatel, Jazztel, Ya.com and Fon, followed by fertility technology and mobility ventures. These career descriptions are distinct from company-level Myelin investments or personal cash checks; the current manager directory supplies his Myelin title.

Matías Nisenson is a general partner at Myelin VC. Native SEC fund disclosures identify him by the fuller name Matias Alan Nisenson as an executive officer and authorized signatory for three Myelin legal vehicles associated with Myelin II Management LLC. His own Myelin publication author profile identifies his earlier founder role at Tiempy. The firm describes its investment team as founders turned investors and its mandate as industry-agnostic seed through Series A.

Alicia Moy is a published Xfund Fellow. The directory supplies this professional context: Alicia Moy Managing Director, The Harvard Shop. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Amina Kalandarova is a published Xfund Fellow. The directory supplies this professional context: Amina Kalandarova Xfund Fellow. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Siddarth Rout is a published Xfund Fellow. The directory supplies this professional context: Siddarth Rout VP Partnerships, Columbia Organization of Rising Entrepreneurs. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Matthew Musson is a published Xfund Fellow. The directory supplies this professional context: Matthew Musson President, Stanford BASES. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Xfund publishes one named Fellow with the typographically duplicated display “Saaim Saaim Khan”. This profile uses Saaim Khan for that single published person and original named portrait, while preserving the source spelling here. No unrelated Saaim developer profile or legal-name alias is inferred.

Ibrahim Omeesh is a published Xfund Fellow. The directory supplies this professional context: Ibrahim Omeesh Xfund Fellow. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Han Lee is a published co-lead of Xfund Ethics Fellows. The named original portrait identifies Han Harrison Lee, corroborated by Stanford’s2025 entrepreneurship report naming Han “Harrison” Lee in its ethics-fellow context. This is distinct from unrelated biotech investors or other Han Lee homonyms.

Sasha Zhang is a published Xfund Fellow. The directory supplies this professional context: Sasha Zhang Vice-President, Stanford BASES. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Mizuki Yashiro is a published Xfund Fellow. The directory supplies this professional context: Mizuki Yashiro Director, Harvard Undergraduate Venture Capital Group. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Lucas Westphal is a published Xfund Fellow. The directory supplies this professional context: Lucas Westphal Xfund Fellow. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Asha Khurana is a published Xfund Fellow. Her linked profile describes Harvard economics/philosophy study and leadership in Harvard Student Agencies. Student-agency operating totals are not Xfund staffing, assets or fundraising.

Justin Hou is a published Xfund Fellow. His linked biography describes Columbia computer-science study, robotics research and campus entrepreneurship/incubator leadership, with interests in NLP and computational biology. This fellowship is distinct from employment as an investment professional.

Nathan Georg is a published Xfund Fellow. His linked biography describes Harvard economics/statistics study and leadership of an undergraduate government-technology incubation programme. Source-aged student titles are not assigned invented appointment dates.

Jeppe Nielsen is listed by Brewer Lane as External Advisor — Insurance. This is the firm’s separately published external advisory network, providing sector and operating knowledge to the ventureplatform, rather than an inferred employee or legally named fundGP. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Dick Mucci is listed by Brewer Lane as External Advisor — Benefits. This is the firm’s separately published external advisory network, providing sector and operating knowledge to the ventureplatform, rather than an inferred employee or legally named fundGP. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Kaitlyn Hou is a published Xfund Fellow. Her linked profile describes Harvard applied-mathematics study and undergraduate emerging-markets programme leadership. These are source-published student/community affiliations, not a manager investment-partner position or personal check.

Paul Mang is listed by Brewer Lane as External Advisor — Risk Analytics. This is the firm’s separately published external advisory network, providing sector and operating knowledge to the ventureplatform, rather than an inferred employee or legally named fundGP. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Joan Lamm-Tennant is listed by Brewer Lane as External Advisor — Insurance & Benefits. This is the firm’s separately published external advisory network, providing sector and operating knowledge to the ventureplatform, rather than an inferred employee or legally named fundGP. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Jonathan Zittrain is a published Xfund faculty/advisory affiliate. The directory supplies this professional context: Jonathan Zittrain George Bemis Professor of International Law, Harvard Law School. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Don Wood is a published Xfund faculty/advisory affiliate. The directory supplies this professional context: Don Wood Managing Director Emeritus, DFJ. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment. Current primary B Capital biography reviewed October8,2026: Don Wood is a Venture Partner at B Capital, where he focuses on Energy and Resilience Tech investments. Before joining B Capital, he was a Managing Director at DFJ. As a Venture Partner and Advisor at Energy Impact Partners, Piva Capital and B Capital, he and his firms helped to fund over 800 companies across climate, space, consumer Web and enterprise IT, including 40 that have achieved billion dollar or greater valuations (SpaceX, Planet, Coinbase, Tesla, Ring, Redfin, Twilio, SolarCity, Twitter, Box, AthenaHealth, NetApp and Skype). Since 2014, he has been on the faculty of the Stanford Graduate School of Business, teaching classes in both Climate Tech and Entrepreneurship. Previously, Don worked at the U.S. Environmental Protection Agency, as a consultant at McKinsey & Company, as the Senior VP of Sales and Marketing at International Power Technology and as Director of Product Marketing at Octel Communications (OCTL). He co-founded Wood-Howard Products with his patent for a laminated publishing format, selling over 100 million products under licenses. Don has served as Board member for 15 public and private companies, including wireless internet pioneer Metricom (MCOM), where he was also the President.

Douglas Kim is listed by Brewer Lane as External Advisor — Go-to-market & Enterprise Software. This is the firm’s separately published external advisory network, providing sector and operating knowledge to the ventureplatform, rather than an inferred employee or legally named fundGP. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Timothy Corbett is listed by Brewer Lane as External Advisor — Asset Management. This is the firm’s separately published external advisory network, providing sector and operating knowledge to the ventureplatform, rather than an inferred employee or legally named fundGP. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

David Brown is listed by Brewer Lane as External Advisor — Asset Management. This is the firm’s separately published external advisory network, providing sector and operating knowledge to the ventureplatform, rather than an inferred employee or legally named fundGP. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented. Thisassetmanagementadviser is keptseparate from the existingImYoo CTO DavidBrown; nopersonaliasproofconflatesthem.

Jae Yoon is listed by Brewer Lane as Strategic Investment Lead. This current operating affiliation supports the Boston ventureplatform investing in financial, insurance and healthcaretechnology. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Michael Baresich is listed by Brewer Lane as External Advisor — Technology Strategy & Go-to-market. This is the firm’s separately published external advisory network, providing sector and operating knowledge to the ventureplatform, rather than an inferred employee or legally named fundGP. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Suraj Srinivasan is a published Xfund faculty/advisory affiliate. The directory supplies this professional context: Suraj Srinivasan Phillip J. Stomberg Professor of Business Administration, Harvard Business School. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Deborah Spar is a published Xfund faculty/advisory affiliate. The directory supplies this professional context: Deborah Spar Jaime and Josefina Chua Tiampo Professor of Business Administration, Harvard Business School. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Martha Notaras is listed by Brewer Lane as General Partner. This current operating affiliation supports the Boston ventureplatform investing in financial, insurance and healthcaretechnology. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Michael Smith is a published Xfund faculty/advisory affiliate. The directory supplies this professional context: Michael Smith John H. Finley, Jr. Professor of Engineering and Applied Sciences, Harvard University. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Rohan Malhotra is listed by Brewer Lane as General Partner. This current operating affiliation supports the Boston ventureplatform investing in financial, insurance and healthcaretechnology. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

John Kim founded Brewer Lane Ventures and is its managingpartner. The ownhostedNAICprofile describes his previousleadership ofPrudentialRetirement,CIGNARetirementandInvestmentServices,AeltusInvestmentManagement andNewYorkLife, where he waspresident/CIO andledNewYorkLifeVentures. Officialfundfilings identifyhim asmanagingmember ofthefundGP. Thisfinancialservicesexecutive isdistinct fromthePresenceAIcofounder,Contralineregulatoryexecutive andLilaSciencescorporatedevelopmentexecutive sharinghisname.

Courtney Howe is listed by Brewer Lane as Business Manager. This current operating affiliation supports the Boston ventureplatform investing in financial, insurance and healthcaretechnology. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Rhonda Shrader is a published Xfund faculty/advisory affiliate. The directory supplies this professional context: Rhonda Shrader Executive Director, Berkeley HAAS Entrepreneurship. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Chris Downer is listed by Brewer Lane as General Partner. This current operating affiliation supports the Boston ventureplatform investing in financial, insurance and healthcaretechnology. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Bob Pozen is a published Xfund faculty/advisory affiliate. The directory supplies this professional context: Bob Pozen Senior Lecturer, MIT Sloan School of Management. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Kaitlin Derry is listed by Brewer Lane as Senior Associate. This current operating affiliation supports the Boston ventureplatform investing in financial, insurance and healthcaretechnology. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Adam Cloud is listed by Brewer Lane as Operating Partner. This current operating affiliation supports the Boston ventureplatform investing in financial, insurance and healthcaretechnology. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Cherry Murray is a published Xfund faculty/advisory affiliate. The directory supplies this professional context: Cherry Murray Benjamin Peirce Professor of Technology and Public Policy and Professor of Physics, Harvard University. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

David Castellani is listed by Brewer Lane as Operating Partner. This current operating affiliation supports the Boston ventureplatform investing in financial, insurance and healthcaretechnology. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Harry Lewis is a published Xfund faculty/advisory affiliate. The directory supplies this professional context: Harry Lewis Gordon McKay Professor of Computer Science, Harvard University. This undated published affiliation is scoped to the Xfund advisory/community network; it does not establish an investment-partner appointment, cash contribution, personal check or independently verified current outside employment.

Rakesh Khurana is a published Xfund faculty/advisory affiliate and Harvard leadership/organizational scholar. Xfund names his professorial affiliation; his2014–2025 Harvard College deanship is historical and is not imported as a current dean appointment.

Ron Bucchi is listed by Brewer Lane as Head of Finance. This current operating affiliation supports the Boston ventureplatform investing in financial, insurance and healthcaretechnology. The own directory verifies this position and name-bound portrait; further personal education and priorcareer are not supplied there and are not invented.

Habib Haddad is a published Xfund faculty/advisory affiliate. His biography describes E14’s MIT Media Lab-linked investment work, prior Wamda leadership and co-founding Arabic-language technology company Yamli. The named NLP and entrepreneurship work is career context rather than proof of an Xfund investment.

Paul Gompers is a published Xfund faculty/advisory affiliate and Harvard Business School finance scholar. His research concerns entrepreneurial finance, venture capital and private equity; the published biography describes Harvard biology and business-economics study and Oxford economics graduate training.

Elise Bates is a published Xfund faculty/advisory affiliate. Her linked profile describes Harvard Business School innovation and entrepreneurship programme leadership, an MBA and operating experience in healthcare and consumer ventures. Its differing innovation/Rock Center titles are undated context, not a independently established outside appointment date.

Jadyn Bryden is an Xfund Venture Partner in the current published team directory. Her undated individual biography retains the older Vice President title, which is qualified rather than imported as a second current job. Her published background includes Harvard Student Agencies leadership and campus entrepreneurship programmes.

Prat Mallick is an Xfund Principal based in its Cambridge/Harvard Square network. His published biography describes founding a Y Combinator cybersecurity company, AI government-contracting work and research on AI safety and responsible adoption. The profile connects technical entrepreneurship, research and institutional policy without implying a personal investment in every project.

Tuan Ho is an Xfund Partner and entrepreneur whose published background includes co-founding Philo, building Raydiant and working as a founder in residence at Atomic. His education includes Harvard chemistry/physics and public-policy study. The biography discusses AI-enabled customer experience, entrepreneurship and policy; undated outside-company titles are not newly asserted current appointments.

Brandon Farwell is an Xfund General Partner. His published background includes technology investing at DFJ and Rothenberg Ventures and commercial experience at Box. His research and investment interests include applied AI, robotics, autonomy, mixed reality and space technology; prior-employer investments are distinct from current Xfund checks.

Patrick Chung is Xfund’s Managing General Partner and2014 co-founder. His published biography describes earlier NEA consumer and seed-investing leadership and previous work at McKinsey and internet-services company ZEFER. His education spans Harvard environmental science, a Harvard joint law/business degree and Oxford graduate study. Named career investments span earlier employers and are not presumed personal or exclusively Xfund checks.

Ronit Dey is named by Gravity founding-growth team member JoshHamilton in the company’s public funding-launch team acknowledgement. This establishes a source-qualified published team contribution to Gravity, not a specific leadership or engineering title, exact employment interval, degree or authentic portrait.

Ian Patrick Tan is named by Gravity founding-growth team member JoshHamilton in the company’s public funding-launch team acknowledgement. This establishes a source-qualified published team contribution to Gravity, not a specific leadership or engineering title, exact employment interval, degree or authentic portrait.

Myles Iyabor-David is a founding engineer at Gravity according to its current ownAbout directory and exact public professional profile. His own Devcore biography identifies him as its founder, with earlier dataanalytics engineering atONEOK, computer-science study atUniversityofTulsa and AI/ML study atColoradoStateUniversity. Those studies and previous roles remain self-published career claims; Devcore marketing performance claims are not treated as independent outcomes. Its own named founder image supplies an authentic portrait, visually inspected and faithfully resized.

Noah Crawford is named by Gravity founding-growth team member JoshHamilton in the company’s public funding-launch team acknowledgement. This establishes a source-qualified published team contribution to Gravity, not a specific leadership or engineering title, exact employment interval, degree or authentic portrait.

Josh Hamilton is identified as Founding Growth at Gravity in the ownAbout directory. His self-authored May2026 Medium article uses the full name JoshuaHamilton and describes growth engineering, AI-native advertising and prior operation of a B2Bgrowth consultancy serving160-plusclients across60industries. His public professional biography and owncompanylaunch post link the exacttrygravity.ai company and acknowledge its eight named public team contributors. Consultancy metrics are self-reported. No unverified career dates or portrait from a namesake baseball player are inferred.

Leo Martinez is Gravity’s cofounder and CTO. His own personal website identifies his work as monetizing AI and his location as SanFrancisco. Gravity’s current ownAbout directory names the same cofounder/CTO and links his public professional identity. His supplied technical remarks to MongoDB describe evaluating retrieval/reranking models to match ads to AI conversations. No precise academic degree, earlier employment or authentic photographic portrait is asserted from the company’s illustrated group image.

Sanket Srivastava is a founding engineer at Gravity according to its current ownAbout directory. His exact public professional profile identifies Gravity inSanFrancisco and an engineering background in appliedmathematics and data science; it lists NortheasternUniversity study2023–2025 and coursework in optimization,numericalanalysis,machinelearning and algorithms. Earlier volunteered research support at LaureateInstitute forBrainResearch is datedFebruary–August2020 in his self-published career history, not a current neuroscience employer. No degree title or authentic photographic portrait is inferred where omitted.

Zach Oldham cofounded Gravity and leads the AI advertising network as CEO. His own personal and Delphi biographies describe building contextual advertising infrastructure to help fund access to AI. Previously he founded Flax Labs after developing advertising-profit attribution software as a teenager and bootstrapped it into a45-person services business and brand incubator; he identifies Jean Lavigne as its subsequent leader. These are self-published career claims, not a currentFlax managerial role. His Delphi profile supplies an authentic named portrait, visually inspected.

Gravity is the AI advertising network operated by IRIS Inc., based in San Francisco. Its contextual ad infrastructure connects brands with AI chatbots, assistants and agents, embedding sponsored recommendations within generated conversations and giving AI application developers a monetization channel. Its own product describes an ad exchange and developer integration, with contextual retrieval and matching; usage, revenue and performance figures are company-reported. The current applicable July27,2026 terms name IRIS Inc.; separately posted terms effectiveOctober19,2026 explicitly identify the same provider doing business as Gravity and are a future version at this October8 audit. Older homepage structured metadata uses Iris Technologies. Gravity was founded in2025 by CEOZachOldham and CTOLeoMartinez. The own About directory names five human team members; a recent public team announcement additionally names three contributors without job titles. The About group image is an official painted illustration and is not represented as authentic photographic portraits. Own issuer disclosures confirm a seed led by CaffeinatedCapital and SeriesA co-led by Lightspeed and CommittedCapital; reported38Mtotal is rounded cumulative funding, not additional financing. This company is distinct from legacy gravity.com personalization, gravityplatform.com energy reporting, gravityai.com ML containers and other namesake Gravity businesses.

ROM Utrecht Region is a Dutch regional development and investment organisation established in 2020, operating as ROM Regio Utrecht B.V. It supports innovative companies in Utrecht province and the Gooi and Vechtstreek through venture financing, business development and international expansion. Its investment themes cover life sciences and healthcare, sustainable industry and the built environment, and digital technologies including AI, cybersecurity and immersive technology. It provides early-stage and growth financing through separate funds, typically alongside private investors, and also commits capital to specialist venture funds. Beyond financing, its staff connect entrepreneurs with researchers, public partners and international markets, support innovation programmes and help portfolio companies grow. ROM also manages the Dotslash Utrecht Fund launched in July 2026.

General director of ROM Utrecht Region. The firm’s 2025 annual report names him as its director and identifies his background in entrepreneurship research at Tilburg University. The current own team directory and his signed June 2026 report establish the same executive affiliation.

Ileana Lindeman is published as a Crainio advisor and is a statutory director of Crainio Limited. Companies House records her director appointment on May 11, 2026.

Jeremy Holland led Crainio as CEO until the company announced his departure in July 2026. NLC described his background in science, technology development, AI, software and medical devices. Companies House records his statutory directorship of Crainio Limited from September 21, 2022 to July 1, 2026. The precise end date of his CEO role is undisclosed.

Peter Phillips is published by Crainio as advisor.

Tim Cooke is published as a Crainio advisor and is a statutory director of Crainio Limited. Companies House records his director appointment on May 11, 2026.

Crainio develops a non-invasive brain-monitoring device intended to detect intracranial hypertension, including in patients with traumatic brain injury. A small forehead sensor uses low-power near-infrared light to record cerebral pulse signals; signal processing and machine-learning algorithms analyze those signals to identify elevated pressure inside the skull. The company designs the system for continuous monitoring and a simple hypertension indication, aiming to make brain-pressure assessment accessible beyond invasive monitoring in intensive care. It is a London-based medical-device company originating from optical-sensing research at City, University of London. Its current development program includes a multisite clinical feasibility study and research into monitoring during ambulance transfers. The company lists pivotal testing and regulatory approval as future steps, so the product remains in clinical development. Its legal company is Crainio Limited, incorporated in 2022.

Alex Stokoe is published by Crainio as head of product.

Chadi Hajj is published by Crainio as head of data science.

Christopher Uff is Crainio’s chief medical officer, supporting its clinical-development program. The company publicly named him as the Royal London Hospital feasibility study’s consultant-neurosurgeon lead.

Maria Roldan Restrepo is Crainio’s founder and CEO. The company announced her transition from CTO to CEO in July 2026, maintaining leadership from the technology’s scientific and technical development.

Nicky Owen is Crainio’s published patient advocate. This is a patient-representation affiliation rather than an inferred employee or officer position.

Ozgun Mavuk is published by Crainio as clinical research assistant.

Panicos Kyriacou is Crainio’s founder and chief scientific officer. He led the underlying optical-sensing research at City, University of London and is named as the inventor in NLC’s venture launch.

Sara Lombardi is published by Crainio as signal processing engineer.

Yoana Bobeva is published by Crainio as clinical research assistant.

Chase Overlie is publicly identified with NVentures as Investment Team — published NVIDIA GTC affiliation. NVIDIA’s 2026 GTC programme and panel introduction identify him with NVentures. This published investment-team affiliation does not establish a formal seniority title, appointment date or personal investment. A genuine attributable portrait remains unverified.

Vega Shah is publicly identified with NVentures as Platform Lead. She supports portfolio-company technical and ecosystem integration. Her NVIDIA biography describes a background in science and product management, a University of Washington genomics PhD and UC Berkeley biology degree.

Mohamed Siddeek is publicly identified with NVentures as Vice President and Head of NVentures. Known as Sid Siddeek. He leads NVIDIA’s venture-investment unit. His published biography describes earlier investment and operating experience, a Yale degree, Wharton MBA and engineering studies at Oxford. A 2026 SEC agreement identifies him as President and Managing Director of NVentures and NVIDIA Vice President.

Chris Lin is explicitly listed in the current published Guidewire Ventures investment team, the internal corporate investment arm of Guidewire Software. The public named team card contains an authentic portrait but does not publish a specific rank, professional biography, education or tenure dates. No similarly named unrelated investor or principal title is substituted.

Jay Grayson is explicitly listed in the current published Guidewire Ventures investment team, the internal corporate investment arm of Guidewire Software. The public named team card contains an authentic portrait but does not publish a specific rank, professional biography, education or tenure dates. No similarly named unrelated investor or principal title is substituted.

Sabrina Hou is explicitly listed in the current published Guidewire Ventures investment team, the internal corporate investment arm of Guidewire Software. The public named team card contains an authentic portrait but does not publish a specific rank, professional biography, education or tenure dates. No similarly named unrelated investor or principal title is substituted.

Alexander has served on our Board since August 2026. He served as Chief Operating Officer of AXA SA and Chief Executive Officer of AXA Group Operations from December 2021 to December 2025. During this time, he was also a member of AXA's Group Management Committee. Prior to that, he served as Chief Executive Officer of AXA Germany from September 2016 to December 2021. Before joining AXA, he spent more than seven years at Allianz Deutschland AG in a series of senior leadership roles, culminating in his appointment as Chief Executive Officer of its German P&C business, a position he held from January 2014 to September 2016. Earlier in his career, he spent nine years at McKinsey & Company, where he became a Partner and advised leading financial services institutions across multiple markets on strategy and large-scale transformation programs. He currently serves as Senior Advisor to AXA's Group Management Committee.

Jeff has served on our Board since January 2025. He was the Chief Executive Officer of Global Payments Inc. (NYSE: GPN), a leading worldwide provider of software solutions and payments technology, from October 2013 to June 2023. Prior to that, he was Global Payment’s president from June 2010 to September 2013. Between September 1998 and May 2010, he held various executive positions at Goldman Sachs, including as worldwide head of the financial technology group and partner. With Goldman, Mr. Sloan focused on mergers and acquisitions and corporate finance, and he pioneered the development of the firm’s financial technology practice in investment banking. He has also served on the boards of directors of Corpay (NYSE: CPAY) since July 2013, NCR Voyix (NYSE: VYX) since March 2025, and Verifone, Inc. since June 2025.

David has served on Guidewire’s board of directors since October 2022. He currently serves as Managing Partner and Co-Founder of Holding Ground Decision Intelligence LLC, which provides strategic technology assessment and diligence services for investment companies, boards, and executives, a position he has held since January 2020. From November 2014 to January 2020, David served as Managing Partner at Sand Hill East LLP and provided early-stage companies with go-to-market, product, security, technology, and operations advisory services. He also previously served as CTO at Asurion, and CISO at Morgan Stanley and Merrill Lynch.

Margie has served on Guidewire’s board of directors since 2019. From December 1993 to September 2017, she held various executive positions at Liberty Mutual Insurance Company, including Senior Vice President and Chief Financial Officer, Personal Insurance, and Executive Vice President and Chief Customer Officer, US Consumer Markets. Margie has also served on the board of directors of White Mountains Insurance Group, Ltd since May 2021, and the board of Hi Marley since February 2022.

Rajani has served on Guidewire’s board of directors since June 2021. She is currently a director and an advisor/investor to several public and private technology companies in the AI, VR, blockchain, IMU/sensor, BIM technology space. Since October 2021, she has served on the board of Hayden AI, a smart city solutions provider that developed the world’s first autonomous traffic management platform. Since May 2023, she has served on the board of Sportradar, a public company that is the world's leading sports technology company, at the intersection between sports, media and betting. Previously, she has served on the board of companies such as Faro Technologies, ESI and Cloudcherry. From June 2000 to March 2014, Rajani held a variety of leadership roles at Salesforce, most recently Chief Operating Officer and Executive Vice President – Technology and Products.

Mark has served on our Board since 2024. He was President and Chief Operating Officer of Verisk Analytics, Inc. (Nasdaq: VRSK), an insurance industry data analytics and technology provider through 2023. Prior to that, Mark served as Verisk’s Chief Financial Officer from 2007 to 2016, leading the company through its 2009 IPO. Since 2023, he has been a member of the board of directors of TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company. He currently serves as the chair of its audit committee and as a member of its compensation and innovation & technology committee. Mark has also served on the board of directors of RegEd, a RegTech solutions and compliance software provider for the financial services industry since 2025.

Mike has served on Guidewire’s board of directors since 2019 and has been Chairman of our Board since March 2024. Since April 2019, he has served as chairman of Guidewire’s customer Strategic Advisory Councils. Mike has also served on the board of Encova Mutual Insurance Group since August 2020. From June 2001 to June 2018, Mike was the Executive Vice President and Chief Information Officer at Nationwide Insurance and Financial Services. From January 1998 to May 2001, he served as Chief Technology Officer at JPMorgan Chase & Co. (formerly Bank One).

David leads Guidewire’s Global Sales, Inside Sales, and Solution Sales organizations. David is a proven senior executive with deep domain expertise in driving high performance organizations that focus on customer success. He also has vast experience working with customers across many industries on their cloud transformation journey. David has held several senior leadership positions at SAP & Salesforce. Most recently, David was the former Senior Vice President (SVP), Financial Services and Banking for North America Cloud and Technology at Oracle. In this role, he helped customers identify value and drive collaborative strategies to best meet their business goals in moving to the cloud. The current public directories still list commercial/sales leadership, while company earnings-call statements reproduced elsewhere report2026 succession to Shane Cassidy. A currently accessible primary transcript has not been recovered; this biography records directory-listed responsibilities and leaves current tenure unresolved.

Michael Mahoney leads Guidewire’s Global Professional Services organization, helping customers adopt, scale, and realize value from the Guidewire Cloud Platform. With more than 25 years of experience in enterprise software and transformation, Michael has built and led services organizations that drive cloud growth and measurable outcomes. At Guidewire, he has repositioned Professional Services to co-engage with partners around a solutions-oriented portfolio and advance AI-enabled delivery that accelerates adoption and improves customer success. Prior to Guidewire, Michael led SAP’s $1.6B North America Services business and held senior roles across services sales, operations, and regional leadership. Earlier in his career, Michael held roles at Deloitte Consulting, advising enterprise clients on large-scale business and technology transformation.

Diego has held numerous executive positions overseeing technology and product development in the San Francisco Bay Area, India, and Europe. In his role at Guidewire, he drives design and strategy to implement engineering goals that address the needs of P&C insurers, such as the requirement to rapidly bring new and differentiating insurance products to market. Prior to Guidewire, Diego served as Vice President of Software Development and Vice President of Product and Engineering at SAP Labs. He began his enterprise software career at Baan in the Netherlands.

Brian leads Guidewire’s global marketing efforts, including demand generation, branding, and communications. Brian joined Guidewire in 2006, and during his tenure the company has been recognized as an industry-leading brand serving customers in more than 30 countries. He previously was Vice President of Marketing for PeopleSoft’s supply chain division and held marketing leadership and product marketing roles at Ketera, Ariba, and Tradex. Brian serves on the board of directors of Betterview, an insurtech that provides a geospatial predictive analytics platform for P&C insurance.

Brigette McInnis-Day is the Chief People Officer of Guidewire, bringing over 25 years of experience leading HR, operations, and organizational transformation at UiPath, Google Cloud, SAP, and Mercer. She is recognized for advancing inclusion, scaling global teams, and embedding AI and automation into HR to drive business growth. Brigette holds a Master’s in Industrial/Organizational Psychology and was named one of the Top 50 Women Leaders of Philadelphia (2024).

As Guidewire’s Chief Customer Officer, Christina helps customers to realize optimal value through their journey with Guidewire. Previously, Christina led cloud sales strategy globally at Guidewire, leveraging her commercial and operational cloud experience. She brings deep consulting knowledge to Guidewire programs as well as SaaS proficiency from her 15 years at Capgemini. Christina also spent four years on the executive leadership team of Virtustream, the mission-critical cloud company of Dell Technologies.

David brings deep financial leadership to his role as Chief Accounting Officer at Guidewire, where he previously served as Corporate Controller overseeing core accounting and financial operations. Before joining the company, he worked as a consulting chief financial officer, advising organizations through complex financial decisions. He also held senior finance roles, including Chief Financial Officer, Chief Accounting Officer, and Corporate Controller, at Keynote Systems, a marketing software company.

Winston is responsible for Guidewire’s worldwide administrative functions, including business technology, legal, and corporate services. He also manages Guidewire’s corporate and compliance matters, as the company’s General Counsel and Secretary. Prior to Guidewire, Winston served as EVP, General Counsel, and Secretary at Infogroup and also worked at WilmerHale, an international law firm. Winston served as a clerk to Judge Bruce Selya on the US First Circuit Court of Appeals.

As Chief Financial Officer, Jeff is responsible for Guidewire’s financial operations, which includes FP&A, accounting, investor relations, facilities, and procurement. He contributes to strategic planning and helps assess risks and opportunities. Previously, Jeff oversaw company financials as the Vice President of Finance at Guidewire. Prior to that, he was the Chief Financial Officer at GoodData and Vice President of Finance at Rally Software. Jeff began his career as an investment banker focused on the software industry.

John leads Guidewire’s Global Sales, Delivery Services, and Customer Success organizations. He is an accomplished senior executive with more than 25 years of experience in driving high-growth teams to shape and deliver industry transformation. As head of the $4B+ North America Business Unit at Capgemini, John led a global team of professionals in delivering innovative solutions that support the strategic growth of the world’s leading brands. Previously he had led the Capgemini Insurance Business Unit, overseeing the expansion of Capgemini’s global insurance business. He began his career with eight years at Accenture.

Mike Rosenbaum joined Guidewire as Chief Executive Officer in 2019 and has served on our board since then. Since Mike’s arrival, Guidewire has cemented its position as the leading cloud platform serving the P&C insurance industry, growing cloud adoption by over 500%, tripling cloud revenue, and expanding the Guidewire partner ecosystem to become the largest in P&C insurance. Mike’s focus on delivering value for customers, coupled with his “ship, shipmate, self” approach to prioritization, continue to shape the industry-leading platform, applications, and content trusted by insurers globally. Prior to Guidewire, Mike led product management and go-to-market strategy for core CRM products at Salesforce and served in the US Navy as a submarine officer. He has also served on the board of directors of Docusign, Inc. (NASDAQ: DOCU) since September 2025.

Caitlin Ner was published as PsyMed Ventures’ Chief of Staff in its Q1 2023 update. Her background includes Harvard studies, investing at BlackRock and growth and operations work at Cerebral. Her current PsyMed position is unverified.

Kevin Kickhaefer advises Fourier Health. The company lists him as ParetoHealth chief revenue officer and cites previous Gravie growth leadership and ConsumerMedical CEO experience.

Molly Coye, MD, advises Fourier Health. The company identifies former Aetna board and UCLA Health chief innovation affiliations. Senior Advisor in Despierta’s venture-partner roster and additionally listed under its combined advisors/select-LPs section; the latter does not establish a specific personal LP commitment. Her published biography describes health-system innovation, AVIA involvement, former UCLA Health innovation leadership and earlier public-health leadership. Historical outside positions are not presumed current.

Emily Maxson, MD, advises Fourier Health. The company identifies her as Aledade’s founding and former chief medical officer. Named Partner in Despierta’s public venture-partner roster. The manager publishes a named portrait but no substantive biography in that entry. This source establishes the affiliation without guessing its start date, employment terms or personal investment amounts.

Erkin Otles, MD, PhD, advises Fourier Health. A physician-engineer working in clinical AI, he previously worked at Epic, according to the company’s own adviser biography.

Mahir Jethanandani advises Fourier Health. The company cites former OpenAI human-data work and Scale AI healthcare NLP experience.

Veeral Desai, MBA, advises Fourier Health. The company cites his former chief strategy role at agilon and former Vantage Oncology operations presidency.

Emily Alsentzer, PhD, advises Fourier Health. The company identifies her Stanford assistant professorship and expertise in medical natural-language processing and summarization.

Andy Ellner, MD, advises Fourier Health. The company identifies him as Firefly Health co-founder and former CEO, with a Harvard Center for Primary Care director affiliation. These advisory credentials do not imply a separate Fourier executive appointment. Andrew (Andy) Ellner is listed in Despierta’s combined advisors/select-LPs group. The manager biography identifies Firefly Health co-founding and Harvard primary-care leadership, matching the existing Fourier adviser identity; undated CEO credentials are qualified against Fourier’s former-CEO wording.

Daniel Chaitow advises Fourier Health. The company identifies his previous role as Innovaccer’s chief business development officer.

Marissa Miller, RHIT, leads data quality at Fourier. She has more than nine years of healthcare and medical-records experience as a health information management specialist.

Ashley Williamson, MBA, MSN, RN, is Fourier’s clinical quality assurance manager. Her nursing background spans intensive care, hospice, education and informatics, including leadership work at Nuvance Health.

Kristen Baier, MSN, RN, manages clinical operations at Fourier. Her nursing experience includes oncology, women’s health and navigation for breast and thyroid cancer programmes.

Christine White, BSN, RN, OCN, is VP of clinical operations at Fourier. An oncology-certified nurse, she previously led oncology work at InfiniteMD/ConsumerMedical.

Gabrielle Zurawski, RN, is Fourier’s VP of clinical solutions. Her background combines nursing and clinical workflow implementation, including clinical operations management at InfiniteMD.

Cameron Meade leads implementation at Fourier. She previously led professional services at Vital and worked in integrations at PatientPing, after starting her career at Epic.

Marc Riti directs data and analytics at Fourier. Previously he managed business intelligence at Vital and worked in pharmaceutical commercial analytics consulting at Veeva Systems.

Govind Brahmanyapura is a senior software engineer at Fourier, specializing in early AI products. His previous work includes Sprig AI products and Gopuff advertising technology.

Jared Wilson is a senior software engineer at Fourier. His background spans healthcare, education and analytics; he previously led analytics and experimentation at Dropbox. The current company directory spells his surname Wilson.

Kyle Tilman is a senior software engineer at Fourier, with healthcare data-pipeline experience at Flexpa, Carbon Health and Redox. He founded Carbon Health’s interoperability team.

Chris Hennen is a senior software engineer at Fourier. His healthcare interoperability background includes engineering work at Carbon Health, Redox and Epic.

Kevin Mandich, PhD, is Fourier’s principal AI engineer. Previously he co-founded Sprig and led its AI work. He earned an engineering physics doctorate at UC San Diego.

James Lloyd co-founded Fourier Health and serves as CTO. Previously a Redox co-founder and CTO and Epic engineer, he has more than sixteen years of healthcare technology experience. Listed for Tech and Integration at Despierta. Its own portfolio identifies him and Christopher Lee as Fourier Health founders; the original portrait also matches the existing Fourier CTO identity. This manager affiliation is separate from his protected Fourier co-founder/CTO role.

Christopher Lee, PhD, co-founded Fourier Health and serves as CEO. He previously co-founded InfiniteMD as COO; it was acquired through ConsumerMedical by Alight Solutions in 2021. He earned a Harvard-MIT health sciences and technology doctorate. Co-founder and Managing Partner of Despierta Ventures and co-founder of Fourier Health. The same-person bridge is established by both companies naming his InfiniteMD co-founder/COO history and the Despierta portfolio naming Christopher Lee and James Lloyd as Fourier founders. His own manager biography describes InfiniteMD acquisition through ConsumerMedical and Alight, Akita Biosciences co-founding and Harvard-MIT doctoral research.

Jack joined MTech Capital in 2019. He has worked on >10 investments since joining MTech. Before joining MTech Capital, he spent 4 years with CIL Management Consultants, where he supported leading private equity investors and corporates on financial services and technology transactions. Jack graduated from Oxford University with a BA/MA. He is based in London.

Before joining the MTech team, Taylor De Bruin was involved with multiple start-ups. He brings versatility to MTech Capital in his admin role. His areas of focus have included: accounting, customer support, marketing, quality assurance, website design, and more. Taylor graduated with a BS in Accounting and a BS in Business Administration from the University of Wisconsin-Stevens Point. He is based in Santa Monica.

Nick joined MTech Capital in 2019. He has worked on >10 investments since joining MTech. Before joining MTech Capital, he spent 2 years as an Associate at L.E.K. Consulting, where he specialized in transactional due diligence and growth strategy work for private equity investors and strategics across the technology sector. Nick graduated from Harvard University with a BA in Economics, where he was a member of the Varsity Men's Volleyball team. He is based in Santa Monica.

Kevin McLoughlin co-founded MTech Capital in 2018. He has board roles at Akur8, Corvus, Cybercube, Hypatos, Insurify, Napo, Peppy, Plum Life, Rest Less and Thinksurance. Prior to founding MTech, Kevin spent 22 years in insurance investment banking, most recently as the Global Head of Insurance Investment Banking at Bank of America Merrill Lynch, and prior to that, as Global Head of Insurance Banking at Citigroup. He also spent 7 years as an executive at AIG. Kevin maintains senior level relationships across the insurance industry globally, having advised many of the largest companies during his banking career. Kevin holds an MBA from Columbia Business School and a BA from Boston College.

Brian McLoughlin co-founded MTech Capital in 2018. He has board roles at Embroker, Inshur, Integriant, Matic, OCHO, Openly, Polly, Voxel and Zuub. Prior to founding MTech, Brian was a partner at Upfront Ventures for 14 years, investing in early-stage companies in the financial technology and insurance technology sectors. He and his partners at Upfront managed more than $700 million while he was at the firm. Prior to Upfront Ventures, Brian was the CFO of a VC-backed Fintech company. He holds an MBA from Wharton School of Business and a BA from Rutgers College.

Executive partner at NewVale Capital with a career spanning investment and operating roles. Previous firms include Gurnet Point Capital, Ares Life Sciences and Advent Venture Partners. His education includes biology at Vassar, a Johns Hopkins master’s degree and a Stanford MBA.

Basetime is a Dutch company developing autonomous geodetic monitoring equipment and cloud software for ground movement and infrastructure safety. Its solar-powered Locator One devices use satellite positioning and connected sensors to measure settlement and movement without repeated manual surveying. Locator Two combines absolute 3D GNSS measurements with tilt sensing for permanent monitoring of bridges, railways, quay walls and other infrastructure. Measurements flow into Parvamoti, its cloud platform for processing and validating data, managing devices and projects, displaying trends and sending threshold alerts; customers can also export results or integrate them through an API. The company sells and rents equipment through international partners to contractors, geotechnical and surveying businesses, asset managers and engineering firms. Basetime was formally established in 2021 from a collaboration between Richtlijn Geodesie and SODAQ, with earlier development dating to 2018.

Co-founder and chief technical officer of Basetime. His published employee spotlight describes his role in developing the company’s technology and the Locator One, initially created for automated settlement-rod measurements and expanded to additional monitoring uses.

Business development manager for Europe at Basetime, introduced in its September2026 company announcement. The announcement describes a background in technology commercialization and degrees in mechanical engineering and business administration. His self-profile corroborates the Basetime affiliation.

Leads project management, development and support at Basetime. Joined the company on September1,2021 after earlier collaboration on concepts that became Basetime. His own employee spotlight describes contributions to the Parvamoti platform and the service/support team.

Introduced as Basetime’s marketer in October2023, with published experience in online marketing, copywriting and social-media management. Also explicitly named in the company’s2024 team feature. Current job duties beyond the historical appointment are unverified.

HR and operations advisor introduced by Basetime in March2026. Its announcement describes earlier recruitment work and experience in employment law, contract management, onboarding and employee development.

Named by Basetime in April2025 as its new sales manager for Europe, with a background in commercial management and the geospatial sector. His current role is not independently reconciled with the later frontline directory.

Gerlof de Korte is listed in NAP’s current finance and compliance operations team. The same named finance professional’s public profile locates his work across Tbilisi and Amsterdam; Terabank’s published governance biography identifies him as an independent supervisory-board member since2018 and describes international banking, consultancy and organizational-development experience. The bank-published original portrait is retained with its exact provenance. The current production bank roster differs from its published beta governance page, so no new current bank appointment is asserted here.

Gorana Graßhoff is listed in NAP’s current operations team with responsibility for administration. The firm links her named professional profile. The public manager roster does not publish a longer career biography or original portrait, and unrelated sports or directory entries are not used to invent additional affiliations.

Andrea Emanuelli leads investor relations at NAP. Both the firm’s welcome announcement and his own joining announcement identify the current title. The firm describes his earlier investor-relations work at Project A and electronics/space-systems background. The current NAP roster lists him within operations, rather than its investment-team directory. An unrelated academic with the same name is not this profile.

Eva-Juliane Stark is listed in NAP’s current legal operations team. The Business Angels Germany event organizer identifies her as General Legal Counsel at NAP in2025, following earlier publisher-confirmed counsel work at Cavalry Ventures. Her firm’s welcome announcement describes preceding venture-capital and M&A legal work at POELLATH and her involvement as a business angel; eCAPITAL identifies her as founder of the Venture Ladies network. No personal investment checks are inferred from those career descriptions.

Francesco Sieben is a member of NAP’s current investment team. The firm’s own promotion post identifies his transition from intern to analyst and describes his role in reviving START Berlin and his interest in advanced manufacturing. The current team page publishes his name and professional-profile link; it does not publish an original headshot.

Jackie Kroyer is a vice president on NAP’s investment team. Her own publication author profile and the firm’s promotion post corroborate that title. Her public announcement of joining NAP identifies her preceding work at UVC Partners; the firm’s promotion post describes her focus on AI infrastructure, agentic AI and data. She co-authored NAP’s June2026 explanation of its Zelara investment.

Stefan Walter is an investment partner at NAP and a managing director of NAP Investment Management GmbH alongside Claude Ritter. The retained Cavalry site identifies him as a founding partner. His own NAP publication discusses industrial and regulated vertical AI, arguing for technical founders with direct operational knowledge of factories, energy grids and laboratories.

Mey Cezairli is an investment partner at NAP. Her former employer Project A announced her promotion to principal in September2022 and describes earlier work as a Goldman Sachs analyst in London followed by work building a digital-health startup in Berlin. Conference-organizer Arctic15 publishes her original named speaker portrait and describes her prior Nordic/Baltic investment focus. Those earlier Project A affiliations are historical, rather than concurrent appointments inferred from older biographies.

Fabian Krautwurst is an investment partner at NAP, the Berlin-based European pre-seed and seed manager formerly known as Cavalry Ventures. His own NAP publication author profile also identifies him as a partner. He contributes the firm’s published investment commentary and co-authored its June2026 explanation of the Zelara investment.

Claude Ritter is an investment partner at NAP and one of the two managing directors of its legal manager, NAP Investment Management GmbH. The retained Cavalry site identifies him as a founding partner, and his own author profile identifies his current NAP investing affiliation. He previously co-founded Delivery Hero and led its product organization.

Operating partner affiliated with NewVale Capital; operating partners are expressly nonemployees. His commercial biopharma career includes leadership at Horizon Pharma and CEO roles at Assertio and Valinor Pharma. He founded Apollo Care and studied political science at Norwich University.

Director of administration and operations at NewVale Capital. She previously supported Lime Rock Partners leadership and worked in investment-sector operations and executive support at CRG and Benchmark Capital.

Operating partner affiliated with NewVale Capital; operating partners are expressly nonemployees. Her biopharma leadership includes roles at Bausch Health, Sanofi and GSK, together with CEO positions at development-stage companies. The manager lists industry board affiliations with ICON, Trinity Life Sciences, Bespak, QurAlis, Nykode and Bryn Pharma. She studied chemistry at North Alabama. Beaconcure’s current board directory publishes Anne Whitaker as chairperson; its July13,2026 CEO appointment release specifically calls her Interim Chair. Her pharmaceutical-company leadership and NewVale operating-partner affiliation are preserved separately.

Vice president at NewVale Capital. She previously invested with Merck’s Global Health Innovation Fund and supported portfolio partnerships with Merck. Earlier she consulted on life-sciences digital-health and innovation strategy at Accenture. She studied economics and global health at Middlebury.

Vice president at NewVale Capital. He previously invested in pharmaceutical services and medical technology at Partners Group and Water Street Healthcare Partners, following investment-banking work at Rothschild. He studied finance and international business at Indiana University.

Principal at NewVale Capital. Her previous work at Arsenal Capital Partners covered healthcare, including pharma services and technology. Earlier she worked in healthcare investment banking at J.P. Morgan. She studied economics and Near Eastern studies at Cornell.

Executive partner at NewVale Capital and pharmaceutical commercial leader. He previously headed AstraZeneca’s US business and served as Innocoll CEO. He studied biology at Princeton and earned an MBA at the University of North Carolina.

Managing director at NewVale Capital. Previously a CRG vice president investing in healthcare, particularly pharmaceutical services, he worked with Todd Holmes before joining NewVale. Earlier he advised life-sciences businesses as a Cowen healthcare investment banker. He holds economics and finance degrees from Southern Methodist University.

Vice president leading strategy and portfolio development at NewVale Capital. She previously spent nearly a decade at Alexion, including during its AstraZeneca acquisition, working on business development and transactions in rare and specialty diseases. Earlier she led strategic planning at BioChemics. She holds Stanford economics and Babson MBA degrees.

NewVale Capital is the US life-sciences growth-equity investment manager legally NewVale Capital LLC, SEC exempt reporting adviser CRD328660/file802-130072. Its own regulatory disclosures state reliance on the venture-capital-fund adviser exemption; it is not represented as a fully SEC-registered adviser. Its current own LinkedIn profile dates establishment to2021, while its original2024 fund announcement says2022; the discrepancy is preserved, it backs proven revenue-generating services, software and enabling technologies across the pharmaceutical value chain, including manufacturing, clinical research and supply-chain infrastructure. Founder Todd Holmes leads a current published team of thirteen professionals. Three operating partners are expressly not employees of NewVale or its affiliates, and those external affiliations are qualified. The current portfolio includes Aizon’s pharmaceutical manufacturing AI, Beaconcure’s clinical-trial data validation software, Argonaut manufacturing services, CAI validation services and Noxilizer sterilisation technology. NewVale led Aizon’s USD20M SeriesC announced February8,2024; the literal subscribing fund vehicle and individual ticket are undisclosed. Its May13,2024 original announcement explicitly confirms the final USD167M close of its inaugural fund. The release’s footnote about co-investment special-purpose vehicles attaches instead to the separate nearly USD200M total assets-under-management figure, so combined AUM is not assigned as FundI corpus. The Delaware FundI’s actual USD167M corpus is distinguished from separate SEC-disclosed SPVs, whose unverified closed sizes remain omitted. Actual legal cash-closing days remain unpublished. Existing company board roles and shared professional biographies/portraits are preserved.

Isabel Fields is publicly named as an Associate at Crystal Venture Partners. The firm’s current welcoming announcement describes her work on external relations, institutional LP relationships and evaluating people risk. Her background includes ESG strategy at Hearst and work across Oracle, the United Nations Foundation and Nike. These are source-qualified career affiliations, not inferred current outside employment. The firm’s primary directory supplies her full surname and individual caption-bound portrait.

Cat Jordan is Chief of Staff at Crystal Venture Partners. Her ownApril2025 post describes joining the firm a month earlier and working with founders and limited partners at its annual general meeting. Her public professional profile identifies Syracuse University’s Martin J. Whitman School of Management. Her current public podcast discussion covers AI-assisted work at the venture firm; quoted entrepreneurs in reposts are not treated as company employees or investment checks.

Stephen G. McGovern is Principal at Crystal Venture Partners, focusing on early-stage insurance and technology businesses under the firm’s published specialist thesis. His ownOctober2025 announcement confirms he helped build the first fund with Jonathan Crystal and announced its final close. Sixfold’s own financing acknowledgment names him alongside Jonathan as a representative of its initial institutional backer. A fuller independently verified career biography and current outside-board appointments are not asserted from secondary directories.

MediSim VR builds virtual reality simulation and AI-assisted competency assessment for medical, nursing and allied health education. It supplies institutions with managed VR labs, training stations, repeatable simulation content and instructor analytics. STRIV teaches and assesses clinical procedures through guided and evaluation modes. DIVE lets medical students practice patient histories, examinations and diagnostic decisions with simulated patients. StudySim provides interactive anatomy and physiology learning. The company also markets hospital VR experiences for patient education, acute pain, anxiety and stress, and invites clinical trials; these are issuer-described applications without a verified product-specific regulatory approval or guaranteed clinical outcome. The legal business is MediSim VR Private Limited, incubated in the IIT Madras ecosystem. Its technology combines immersive simulations with haptic interaction and learning performance assessment; claimed AI analytics support feedback, personalized learning and cohort analysis.

Laparoscopic surgeon and MediSim VR co-founder and chief operating officer.

Dental professional who publicly describes working with MediSim VR in healthcare simulation and medical education. Exact formal title and current tenure are unverified.

Healthcare professional with a self-published MediSim VR affiliation at IIT Madras Research Park. Exact formal title and current tenure are unverified.

Medical simulation educator and published curriculum adviser to MediSim VR.

Simulation researcher and published member of MediSim VR’s advisory board.

Technology professional with a self-published MediSim VR affiliation and a background in games. Exact formal title and current tenure are unverified.

Clinical educator who describes delivering MediSim VR simulation training. A partner medical institution names her as the company’s clinical educator in its April 2024 workshop.

Newcastle-trained technologist and MediSim VR co-founder and chief technology officer.

Healthcare professional with a self-published MediSim VR affiliation. Exact formal title and current tenure are unverified.

Published member of the MediSim VR team, featured in its own team spotlight. Exact formal title and current tenure are unverified.

Medical education specialist and published programme adviser to MediSim VR.

Scientist and published scientific adviser to MediSim VR. Its about page associates him with science and technology leadership at a2 Milk, while its homepage associates him with Nova Southeastern University; these are source-published biographies whose current external employment is unverified.

Operations professional whose personally authored June 2024 article identifies him as General Manager of Operations at MediSim VR. Current tenure is unverified.

Technology professional whose own profile identifies MediSim VR experience and a background in Unity, augmented reality and virtual reality software. Exact formal title and current tenure are unverified.

Physician and journalist who describes leading strategic partnerships at MediSim VR. Her published work discusses connecting its clinical training technology with institutional partners.